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ABSTRACT
Five Macaca mulatta were infected with SIV/DELTAB670. 
Approximately 70 days later, this group (SIV) and five age, 
sex, weight matched not SIV-infected (NEG) It mulatta were 
inoculated orally with approximately 3xl010 Campylobacter 
ieiuni.
Small and large bowel mucosal biopsies, bowel 
contents, sera, blood, and rectal swabs were collected 
before and after Ĉ _ ieiuni inoculation. Biopsy cryosections 
were stained with histologic stains and
immunocytochemically for lymphocyte subsets, plasmacytes, 
macrophages, and B-cells. Coded stained sections were 
examined semiquantitatively or quantitatively using 
computerized image analysis. Circulating lymphocyte subsets 
were determined using FACS analysis.
Campylobacter ieiuni was recultured from 4/5 SIV and 
4/5 NEG monkeys on Pl-day three, 3/5 SIV monkeys on Pl-day 
seven, and 1/5 SIV monkeys on Pl-day 28. No clinical signs 
were observed. Very rare, mildly dilated crypts lined by 
flattened epithelium were observed in mucosal biopsies of 
one SIV and one NEG monkey.
As in AIDS, the SIV group had significantly (p<0.05) 
increased numbers of mucosal CD8+ and IgM+ cells. There 
were fewer, but not significantly reduced numbers of IgA+ 
cells in the colonic mucosa.
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CD4+ cells, decreased in AIDS, were not significantly 
different between SIV and NEG groups. Circulating CD4+CD294- 
cells were significantly decreased while circulating 
lymphocytes and CD44- cells approached significant 
reduction.
Following CL. ieiuni inoculation, systemic anti-C. 
ieiuni IgA and IgG responses determined by ELISA had 
similar patterns. For SIV monkeys, 4/5 had no or minimal 
increases in titers while 4/5 NEG monkeys had moderate to 
marked relative increases. The trend of most of the colonic 
but not duodenal contents responses roughly paralleled the 
systemic IgA response.
Comparing measured cell populations or ratios with 
antibody responses suggested correlations but no cell 
population consistently predicted the level of antibody 
responses in individual monkeys.
These studies found that the SIV-infected macaque 
model has mucosal immune system morphologic alterations 
similar to AIDS patients. The alterations are associated 
with a reduced specific antibody response to and prolonged 
colonization by CL. ieiuni but without increased virulence. 





The Acquired Immunodeficiency Syndrome (AIDS) is a 
relatively recently recognized, apparently new disease that 
caused an initial period of fear which has regressed to 
smoldering anxiety among the population at large. The 
initial period of fear resulted somewhat from the penchant 
of the modern media for sensationalism but also from the 
uncertainty and lack of knowledge about a contagious, fatal 
disease.
Recognition of the new syndrome was difficult since 
AIDS is not defined by a single set of signs and symptoms. 
Some of the pathologic features were induced directly by 
the etiologic agent while most resulted from loss of 
immunity to normally commensal microorganisms. Even after 
researchers had recognized that the various presentations 
had a commonality of origin, finding the causative virus 
required time and proved difficult.
Accumulating knowledge about the epidemiology of the 
syndrome indicated that carriers could spread the disease 
for years through sexual activity or blood products before 
becoming ill. Identification of asymptomatic carriers was 
not possible as no diagnostic test was then available. 
Social groups with non-traditional lifestyles for which 
there was an aversion or distaste for on the part of 
"mainstream" society were disproportionally affected due to 
lifestyle practices of some group members. Some individuals
1
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feared not only contracting the disease but also being 
labeled as a member of one of these social groups. Once 
contracted, the disease is associated with a depressingly 
irreversible, slow, deterioration of both physical and 
mental capacities.
Progress has been made, but anxiety persists as the 
virus infects more people in a wider variety of social 
groups and continues to resist traditional approaches of 
prevention and treatment. The feeling of security that 
modern medicine could protect the population against 
epidemics of fatal infectious disease has been shattered.
Though far less recognized by the public because there 
is no known zoonotic potential or threat to food supplies, 
veterinarians are concerned with immunosuppressive 
retroviruses in animal populations. Veterinarians working 
with nonhuman primates are especially affected. Nonhuman 
primates are affected by both natural and experimentally 
induced retroviral immunodeficiencies. The disease 
conditions associated with retroviral immunodeficiencies 
are discouraging to treat because of poor response to 
therapy, frequent reoccurrences, or interference with non- 
retroviral related research investigations.
Gastrointestinal disease frequently associated with 
microorganisms affects approximately one-half of AIDS 
patients and many retrovirally infected nonhuman primates. 
Understanding of the pathogenesis of the gastrointestinal 
dysfunction is crucial to developing treatment modalities.
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Evaluation of the existing animal models of AIDS 
resulted in the choice of the SIV-infected macaque for our 
studies into the effects of immunosuppressive retrovirus 
infection on enteric mucosal immunity against an enteric 
bacterial pathogen. The SIV-infected macaque is generally 
accepted as the best model of AIDS. The immunodeficiency 
develops rapidly within six to nine months expediting 
experimental study. Human immunological reagents that 
cross-react with macaque tissues are commercially 
available. Finally, the model is developed and available at 
the Tulane Regional Primate Research Center.
The objectives of the studies were:
a) Determine if infection of the rhesus monkey with 
SIV induces changes in the different subsets of 
cells in the intestine associated with enteric 
mucosal immunity as occurs in AIDS patients.
b) Determine if infection of the rhesus monkey with 
SIV induces changes in the enteric mucosal immune 
response to an experimentally induced infection 
with an enteric bacterial pathogen.
The format of the remainder of this dissertation 
includes a review of the literature in areas pertinent to 
the subject of this study: 1) morbidity, mortality, cause, 
and pathogenesis AIDS highlighting the gastrointestinal 
dysfunction; 2) normal mucosal immunity; 3) changes in 
mucosal immunity in AIDS patients; 4) need to use animal 
models to study disease; 5) animal models of AIDS; 6)
4
methods of studying mucosal immunity in these animal 
models. Chapter 3 reports on the results of studies 
evaluating changes in cell populations in the intestine 
associated with immune function induced by experimental SIV 
infection. Chapter 4 reports on the results of studies 
evaluating changes in specific antibody response induced by 
experimental SIV infection to an enteric bacterial 
pathogen. Chapter 5 is a summary correlating the results of 
all of the studies and conclusions.
CHAPTER 2 
Literature Review 
The World Health Organization estimates ("News about 
AIDS," 1991) that there have been one million cases of 
Human Acquired Immunodeficiency Syndrome (AIDS) in adults 
and one-half million pediatric cases since the beginning of 
the pandemic. Forty million people are expected to be 
infected with HIV by the year 2000.
AIDS is caused by the retroviruses Human 
Immunodeficiency Virus-1 (HIV-1) and HIV-2 (Fauci, 1988). 
Using polymerase chain reaction technology, the earliest 
documented death probably caused of AIDS was that of a 
British seaman in 1959 ("Opinion," 1990). Calculations 
using a comparison of nucleotide sequences estimate that 
HIV-1 evolved 40 (Smith, Srinivasan, Schochetman, Marcus, & 
Myers, 1988) to 150 (Gojobori, et al., 1990) years ago from 
an unknown source. HIV-2 is thought to have evolved within 
the past 4 0 years from a primate retrovirus (Hirsch, 
Olmsted, Murphey-Corb, Purcell, & Johnson, 1989).
AIDS is characterized by a progressively deteriorating 
clinical course with persistent lymphadenopathy, fever, 
weight loss, diarrhea, a primary meningoencephalitis, 
opportunistic infections, and secondary cancers including 
lymphoma (Yarchoan & Pluda, 1988). Abnormalities in the 
systemic immune system have recently been reviewed by 
Pinching (1990). All subsets of CD4+ lymphocytes are 
depleted. The functions of other cells dependent on CD4+
5
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cells or their products (IL-2, gamma interferon) are altered 
including failure of neoantigen presentation, cytotoxic effect 
induction failure, impaired proliferation response to 
antigen, defective macrophage activation, and impaired 
natural killer cell activity. A polyclonal gammopathy is 
observed with one of the viral glycoproteins being a potent 
activator of B cells (Schnittman, Lane, Higgins, Folks, & 
Fauci, 1986). Since macrophages are CD4+, they may also be 
directly affected by the virus altering their antigen 
presenting function, Fc dependent function and chemotaxis 
(Gendelman, Orenstein, & Baca, 1989). Dendritic cells in 
lymph nodes and Langerhans cells express reduced levels of 
Class II antigens with reduced antigen presenting function 
(Eales, Farrant, & Pinching, 1988).
Fifty per cent of all AIDS patients have 
gastrointestinal involvement (Santangelo & Krejs, 1986).
Thirty to sixty per cent of these have a chronic, watery, 
non-bloody diarrhea (Johanson & Sonnenberg, 1990) 
associated with weight loss and malnutrition (Quinn, Mann, 
Curran, & Piot 1986).
The diarrhea has been associated with a poorly 
characterized enteropathy, gastric hypoacidity, and 
infectious agents. The cause of the enteropathy is unknown.
The villous area and mitotic counts in crypts are reduced 
(Cummins, Labrooy, Stanley, Rowland, & Shearman, 1990).
There is a decrease in villous to crypt length (Greenson, 
Belitsos, Yardley, & Bartlett, 1991) and brush border
7
lactase activity (Ullrich, Zeitz, Heise, L'age, Hoffken, & 
Riecken, 1989). HIV is found in the enteric epithelium 
(Nelson, Wiley, Reynolds-Kohler, Reese, Margaretten, &
Levy, 1988). Although there are no infectious virions, 
viral nucleic acid is found in feces (Yolken, Li, Perman, & 
Viscidi, 1991).
A variety of infectious agents including viruses, 
bacteria, fungi and protozoa known to cause transient 
enterocolitis in immunocompetent patients have been found 
by standard non-invasive diagnostic methods (Dryden & 
Shanson, 1988; Antony, Brandt, Klein, & Bernstein 1988) and 
by biopsy in more occult infections (Greenson, Belitsos, 
Yardley, & Bartlett, 1991). Frequently identified agents 
include cytomegalovirus, Shigella sp., Cryptosporidium 
parvum. microsporidium (Peacock, Blanshard, Tovey, Ellis, & 
Gazzard, 1991), and Campylobacter sp.. Campylobacter s p . 
has been found in 6.7% (3/45) of AIDS patients with and 
8.3% (2/24) without diarrhea (Laughon, et al., 1988) and 
4/59 of HIV infected patients with diarrhea (Peacock et 
al., 1991). Persistent severe CL. ieiuni enteric and 
systemic infections in three AIDS patients that showed 
abnormally low Campylobacter-specific systemic antibody 
responses have been reported (Perlman, et al., 1988).
That many cases of AIDS are complicated by secondary 
enteric infections suggested a dysfunction in mucosal 
immunity (Kotler, Scholes, & Tierney, 1987) similar to the 
above described systemic immune abnormalities. A discussion
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of the current concepts and research findings about defense 
mechanisms at the level of mammalian mucosal surfaces will 
aid in understanding normal mucosal immunity and the 
changes observed in AIDS patients.
Mucosal surfaces are frequently the initial site of 
exposure to potentially pathogenic microorganisms. A 
combination of nonspecific and specific factors are 
involved in preventing infection or at least limiting 
attachment of these microorganisms to the epithelium. 
Nonspecific factors include motility, drastic changes in 
lumenal pH, resident flora, a layer of mucinous coating 
capable of limiting movement of microorganisms, and 
enzymes such as lysozyme, lactoferrin, and peroxidase which 
possess antibacterial activity (McNabb & Tomasi, 1981).
Specific defense mechanisms represent a response by 
local mucosal components coordinated with systemic immunity 
and have been reviewed (Kagnoff, 1987). In response to a 
constant barrage of foreign molecules, approximately 2 5% of 
the mass of the intestinal tract is lymphoid. This gut 
associated lymphoid tissue (GALT) makes the intestinal 
tract the largest lymphoid organ in the body. GALT has been 
morphologically and functionally subdivided into Peyer1s 
patch (PP) and solitary lymphoid nodules, lamina proprial 
lymphocytes (LPL), and intraepithelial lymphocytes (IEL) 
subdivisions. Specialized epithelial cells overlying the PP 
are important in sampling antigens from the intestinal 
contents. Some are termed M cells and only transport
9
undegraded particulate antigen to subjacent macrophages 
(Bjerke & Brandtzaeg, 1988) while others, termed FAE cells, 
express class II histocompatibility antigens on their 
surfaces and may both transport and process antigen 
(Brandtzaeg & Bjerke, 1989) .
Processed antigens are presented to T cells and 
membrane bearing immunoglobulin M (IgM) B cells in Peyer's 
patches and lymphoid follicles (McDermott, & Bienenstock, 
1979; Mahida, Patel, & Jewell, 1989). These antigen 
stimulated, membrane-bearing IgM cells usually switch to 
antigen-specific, membrane bearing immunoglobulin A (IgA) 
cells and IgA is the predominant immunoglobulin subclass 
secreted on mucosal surfaces (Chodirker & Tomasi, 1963). 
Seventy to ninety percent of all plasma cells in the gut 
lamina propria stain for IgA (Kagnoff, 1987). The quantity 
of IgA produced locally in the intestine is larger than all 
the other immunoglobulin isotypes produced in the body 
combined (Russell & Mestecky, 1988).
The change in surface immunoglobulin is facilitated by 
T helper cells termed "switch" T cells (Kawanishi, Ozato, & 
Strober, 1985) which secrete interleukin-2 (IL-2). These 
antigen-stimulated B cells enter the systemic circulation 
before returning to the lamina propria of mucosal surfaces 
via high endothelial lined venules (Jalkanen, Nash, Toyos, 
MacDermott, & Butcher, 1989). In the lamina propria, IL-5 
produced by a different subset of T helper cells induces 
differentiation and maturation into mature IgA or IgM
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secreting plasmacytes (Harriman, Kunimoto, & Strober,
1989). T lymphocytes bearing receptors for the Fc portion 
of the IgA molecule have been shown to enhance or suppress 
secretion of IgA by these plasmacytes (Yodoi, et al.,
1983).
IgA is secreted from the plasmacyte as a dimer joined 
by a molecule termed J chain (Halpern & Koshland, 1970).
IgA dimers bind to another molecule termed secretory 
component [SC] (Brandtzaeg, 1978) produced by and located 
on the basolateral surfaces of enterocytes. Vesicles 
containing IgA bound to SC (slgA) bud off the basolateral 
surface of the enterocyte and are transported 
transcellularly to the lumenal surface where the slgA is 
released into the intestinal lumen (Brown, Kiyoko, Nakane,
& Pacini, 1977).
The importance of slgA in mucosal immunity is 
indicated by increased susceptibility to viruses (Losonsky, 
Johnson, Winkelstein, & Yolken, 1985), bacteria (Melamed, 
Bujanover, Siegman, Schwartz, Zakuth, & Spirer, 1983), and 
protozoa (Ament & Rubin, 1972) in patients with IgA 
deficiencies of various types not caused by AIDS. Naive 
mice implanted with an anti-Vibrio cholera IgA producing 
plasmacytoma generated in syngenic mice were 100% protected 
against oral challenge with 1 0 0 5 0 % lethal doses of virulent 
Vibrio cholera proving that IgA alone could protect against 
this pathogen (Winner, Mack, Weltzin, Mekalanos, 
Kraehenbuhl, & Neutra, 1991).
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Secretory IgA is thought to work primarily by 
agglutination. Bacteria and proteins bound by slgA exhibit 
an increased affinity for the mucus layer and are more 
easily transported away, thereby excluding them from 
contact with the mucosa (McSweegan, Burr, & Walker, 1987). 
Secretory IgA is also capable of virus neutralization as 
demonstrated with reoviruses (McNabb & Tomasi, 1981).
Other possible mechanisms of action for slgA have 
only been demonstrated in in vitro studies. By a process 
termed antibody dependent cytocellular cytotoxicity, 
Salmonella typhi coated with specific slgA were lysed by 
harvested mucosal lamina proprial cytotoxic cells binding 
via isotype-specific receptors (Tagliabue, Villa, Boraschi, 
Peri, DeGori, & Nencioni, 1985). In another study, slgA 
enhanced antibacterial effects of the enzyme 
lactoperoxidase (Childers, Bruce, & Mcghee, 1989).
In addition to the T helper cells (CD4+) described 
above, CD8+ T cells are also found in the lamina propria at 
a ratio of CD4+:CD8+::2:1 in humans (Allison, Poulter, 
Dhillon, & Pounder, 1990). Most CD8+ cells also label with 
markers indicating cytotoxicity, but functional test 
results vary (Targan, Kagnoff, Brogan, & Shanahan, 1987).
Intraepithelial lymphocytes are a poorly defined 
structurally and functionally heterogeneous population of 
cells with possible local natural killer cell activity 
(Marsh, Leith, Loft, Garner, & Gordon, 1988) . Ninety per
12
cent are CD8+ and H336 negative indicating functional 
suppressor activity (Brandtzaeg, et al., 1988).
Though research into the changes in mucosal immune 
response in AIDS patients is limited, changes have been 
observed. Total secretory IgA levels in parotid secretions 
were reduced in AIDS patients with oral infections (Muller, 
Froland, Hvatum, Radi, & Brandtzaeg, 1991). In studies of 
intestinal biopsies from AIDS patients, a significant 
decrease in plasmacytes staining for IgA was noted (Kotler, 
et al., 1987). This finding suggested there may be reduced 
slgA in intestinal secretions as in the parotid secretions. 
A depletion of CD4+ lymphocytes and reversal of the 
CD4+:CD8+ ratio in the lamina propria of intestinal 
biopsies that are similar to the changes noted in 
peripheral blood have been observed in several studies 
(Budhraja, Levendoglu, Kocka, Mangkornkanok, & Scherer, 
1987; Ellakany, Whiteside, Schade, & van Thiel, 1987).
Based on these findings, Strober (1992) suggested several 
mechanisms to explain the putative enteric mucosal 
immunodeficiency. The decreased numbers of lamina propria 
IgA plasmacytes could be due to insufficient switching and 
differentiation factors available to IgM or IgA bearing B 
cells from the decreased numbers of CD4+ T cells in the 
mucosa. The other basic defect could be a suppression of 
IgA B cell differentiation by suppressing factors from the 
increased numbers of CD8+ T (suppressor/cytotoxic) cells in 
the lamina propria.
Because of moral considerations, the long incubation 
time between infection with HIV and clinical AIDS, and 
delayed recognition of infection until late in the course 
of the disease, animal models are needed to understand the 
pathogenesis of the syndrome, test vaccines and develop new 
therapies (Montagnier, 1989). Various animal models using 
one of the human immunodeficiency viruses have been 
reviewed by Desrosier and Ringler (1989). Chimpanzees 
experimentally infected with HIV do develop persistent 
infections but have the disadvantages of being an 
endangered species and seldom developing a clinical 
syndrome similar to AIDS (Alter, et al., 1984). Mice with 
the severe combined immunodeficiency mutation (SCID) that 
have immune systems reconstituted with human hematolymphoid 
cells (SCID-hu) can be experimentally infected with HIV and 
develop an AIDS-like syndrome (Namikawa, Kaneshima, 
Liberman, Weissman, & McCune, 1988). The model is new, not 
readily available, and requires the use of human tissues 
which have a finite life-span within the mouse. Rabbits 
infected with HIV (Filice, Cereda, & Varnier, 1988) are a 
new and little tested model but infection has not produced 
an immunodeficiency syndrome. Macaques experimentally 
infected with HIV-2 have not developed an immunodeficiency 
syndrome (Dormont, et al., 1989).
Experimental reproduction of natural retroviral 
infections in animals have been studied as models of AIDS. 
Cats experimentally infected with the Feline
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Immunodeficiency Virus (FIV) is a promising but new animal 
model (Barlough, et al., 1991). A similarity of the basic 
induced immunological abnormalities exists with AIDS but 
has only recently been defined. A disadvantage of the model 
is the greater than 25 month incubation period. Mice 
experimentally infected with a defective murine leukemia 
virus develop an acquired immunodeficiency referred to as 
MAIDS (Jolicoeur, 1991). A poorly characterized 
immunodeficiency is produced but there are several 
disadvantages as an AIDS model. The causative viruses come 
from different groups within the retrovirus family. Changes 
in T cell subsets, if any, are not known or even if effects 
on T cells are involved in the syndrome. Calves 
experimentally infected with the Bovine Immunodeficiency­
like Virus develop only a relatively mild lymphocytosis 
(Gonda, et al., 1990). Simian Retroviruses 1-5 are found 
indigenous in Asian macaques, spread by saliva, and produce 
a profound T and B cell depletion with a fatal 
immunodeficiency in the terminal stages of the disease 
(Gardner, 1990) . Disadvantages of the model include distant 
relationship between the causative viruses and HIV, 
different but undetermined cell surface virus receptor on T 
lymphocytes, and the ability of many infected macaques to 
mount a successful immune response to the virus.
The generally accepted best animal model of AIDS is 
the Simian Immunodeficiency Virus (SIV) infected macaque 
(Desrosiers & Ringler, 1989). Different strains of the
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lentivirus termed SIV have been isolated from asymptomatic 
African species of nonhuman primates including the sooty 
mangabey (Cercocebus atvs) (Murphey-Corb, et al., 1986) 
which when experimentally inoculated into Asian species of 
macaques causes an immunodeficiency syndrome similar to 
AIDS. SIV has the same number and arrangement of genes as 
HIV and genes of SIV have extensive homology with HIV-2 and 
moderate homology with HIV-1 (Franchini, et al., 1987). 
Regulation of SIV gene expression is similar with HIV 
(Fultz & Anderson, 1990) and both HIV and SIV have tropism 
for the CD4 molecule (Desrosiers & Ringler, 1989).
The SIV-induced immunodeficiency syndrome develops 
typically within 3-5 months after inoculation (Desrosiers & 
Ringler, 1989). A minority of inoculated macaques have 
survived over two years while remaining persistently 
viremic, thereby mimicking some HIV-infected individuals 
(Daniel, et al., 1987). Circulating CD4+ cells are 
decreased (Kannagi, et al., 1986) and blastogenic responses 
of peripheral blood lymphocytes are depressed (Benveniste, 
et al., 1988).
Clinically, the syndrome mimics AIDS closely with 
inoculated macaques developing persistent lymphadeopathy, 
meningoencephalitis, weight loss, fever, diarrhea, and 
opportunistic infections (Desrosiers & Ringler, 1989). In 
one study (King, et al., 1990), 70% of experimentally 
infected monkeys died within one year from opportunistic 
infections including bacterial infections of the intestinal
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tract. In another report, 9 0% of inoculated Macaca mulatta 
had enterocolitis and chronic diarrhea from which were 
isolated enteric bacterial pathogens including 
Campylobacter sp. (Baskerville, et al., 1990). Inflammation 
in the colons of these monkeys varied from mild 
lymphoplasmacytic to acute necrotizing. In a third report 
(Baskin, Murphey-Corb, Watson, & Martin, 1988) 13 of 18 
(13/18) IVL_ mulatta experimentally inoculated with SIV died 
with diarrhea, dehydration, and weight loss as the 
immediate cause of death, and Ch. jejuni or coli was 
isolated from five of these monkeys at necropsy. Lesions in 
the cecum and colon included a thick, rough, reddened 
mucosa with petechia. Exudates adherent to the surface 
included neutrophils, mucus, and fibrin with the lamina 
propria infiltrated by neutrophils and mononuclear cells.
Campylobacter jejuni has been frequently associated 
with enteric disease in the descriptions of human and 
nonhuman primate retroviral immunodeficiencies and has been 
one of the few enteric microorganisms for which a specific 
systemic immunologic response to infection had been sought 
and not found in AIDS patients (Janoff, 1992). Thus C . 
jejuni was selected as the enteric bacterial pathogen for 
use in our experimental studies. Campylobacter jejuni is a 
spiral shaped, 0.5-8 um long by 0.2-0.5 um wide, 
microaerophilic, gram negative, flagellate bacterium 
(Griffiths & Park, 1990) acquired through contaminated food 
or water (Walker, Caldwell, Lee, Guerry, Trust, & Ruiz-
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Palacios, 1986). Mechanisms of pathogenesis involve 
penetration and proliferation in enterocytes (Ruiz- 
Palacious, Excamilla, & Torres, 1981), enterotoxin 
production by some strains (Johnson & Lior, 1984), and a 
possible but unproven role for a produced cytotoxin 
(Guerrant, Wanke, Pennie, Garrett, Lima, & O'Brien, 1987). 
In developed countries, C\_ jejuni typically produces a 
self-limiting enterocolitis with a loose stool to dysentery 
containing leucocytes (Black, Levine, Clements, Hughes, & 
Blaser, 1988). Histopathologic examination of biopsies from 
patients suffering acute illness found acute inflammatory 
infiltrates in the lamina propria of mainly 
polymorphonuclear leucocytes with fewer plasmacytes and 
mononuclear cells (Blaser, Parsons, & Wang, 1980). There 
were diminished numbers of crypts, decreased mucus 
production in crypts, crypt abscesses, and epithelial 
ulceration. In developing countries, the correlation 
between clinical signs and culture results are not as 
strong, especially in the young (Glass, Stoll, Huq, 
Struelens, Blaser, & Kibriya, 1984). Gastrointestinal 
disease in nonhuman primates attributed to natural and 
experimental CL. jejuni infections have been reported (Hird, 
Anderson, & Bielitzki, 1984; Russell, Krugner, Tsai, & 
Ekstrom, 1988).
As noted above, CR. jejuni has been isolated from AIDS 
patients and the SIV-infected macaques with signs of 
gastrointestinal disease. Reports indicate that specific
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antibody-mediated immunity is believed to be important in 
clearance of CL. jejuni and recovery from clinical disease 
(Caldwell, Walker, Stewart, & Rogers, 1983; Johnson, Nolan, 
Wang, Shelton, & Blaser, 1984; Winsor, Mathewson, & Dupont, 
1986; Black et al., 1988). In patients immunocompromised 
due to causes other than AIDS, the prolonged or relapsing 
course of campylobacteriosis has been attributed to the 
lack of a specific antibody-mediated immune response 
(Melamed et al., 1983; Lebar, Menard, & Check, 1985). The 
increased susceptibility of nude mice to experimental 
campylobacteriosis was attributed to the lack of a T helper 
cell-supported specific IgA mucosal immune response 
(McSweegan et al., 1987).
Methods to evaluate the mucosal immune response have 
been described in the literature. Various techniques have 
been reported (Gaspari, Brennan, Solomon, & Elson, 1988; 
deVos & Dick, 1991) for the processing of feces or 
intestinal contents for examination in immunological 
assays. Analysis of extracts of feces using Western blots 
semiquantitatively measured specific anti-Campylobacter 
jejuni and total fecal slgA in culture positive symptomatic 
human patients versus none in healthy individuals (Winsor 
et al., 1986). Enzyme-linked immunosorbent assay (ELISA) 
has been used to measure specific anti-C. jejuni and total 
slgA in intestinal fluids of rabbits experimentally 
infected with Ch. jejuni (Burr, Caldwell, Bourgeois, Morgan, 
Wistar, & Walker, 1988). ELISA was used to measure total
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and specific anti-cholera toxin antibodies by 
immunoglobulin subclass in serum, saliva, and intestinal 
lavages in rhesus monkeys (Taylor, Daniels, & Schmucker, 
1992) . ELISA has been used to measure levels of specific 
anti-C. jejuni and total immunoglobulin by subclass in 
serum from clinical cases of human campylobacteriosis 
(Blaser & Duncan, 1984). Others (Kaldor, Pritchard,
Serpell, & Metcalf, 1983) have reported that 80 to 90% of 
patients with culture positive Campylobacter enteritis also 
had a measurable specific serum immunological response. 
Serum antibody levels have been reported (Jertborn, 
Sevnnerholm, & Holmgren, 1986) to have good correlation 
with gut mucosal antibacterial immune response to Vibrio 
cholera or cholera vaccine. Similarly, increases in serum 
specific anti-Campylobacter IgA may represent a specific 
mucosal IgA response (Blaser, Black, Duncan, & Amer, 1985). 
Culture is another indirect measure of immunity at the 
mucosal level. Colonization time dropped from 2-3 weeks in 
naive rabbits experimentally inoculated with C\_ jejuni to 
less than three days upon rechallenge at a later date (Burr 
et al., 1988) .
No reports of quantitative examinations of enteric 
mucosal lymphocyte subset populations or plasmacytes in 
normal or SIV-infected macaques similar to those described 
above in AIDS patients were found in the literature.
Several studies (Sandusky, Horton, & Wightman, 1986; 
Ormerod, Osborn, Lowenstine, Meyer, Parker, & Smith, 1988)
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have shown that available immunologic reagents used to 
differentially stain most of the cell surface and 
immunoglobulin subclass antigens on human cells cross-react 
with evolutionarily preserved molecules in or on macaque 
cells thus indicating that such studies are possible. In a 
study performed using goat anti-rhesus reagents examining 
the genital tract mucosa (Miller, et al., 1992), decreased 
numbers of all subclasses of immunocytochemically stained 
plasmacytes were observed in the lamina propria from SIV- 
infected, female macaques.
To summarize, AIDS is a new and serious disease threat 
to the human population. Research is necessary to 
understand the pathogenesis of the disease to develop more 
specific treatment modalities. Gastrointestinal 
abnormalities due to primary or secondary causes are 
serious complications in approximately one-half of AIDS 
cases. The SIV-infected macaque potentially provides an 
ethical and scientifically controllable model to further 
study the effects of retroviral induced mucosal 
immunodeficiency indicated by preliminary studies of 
others.
CHAPTER 3
Enteric Mucosal Immune System Cell Populations in Macaques 
Experimentally Inoculated with 
Simian Immunodeficiency Virus and Campylobacter jejuni
Introduction
The 45,506 cases of AIDS reported in the United States 
in 1991 represented a 5% increase over the previous year 
and was influenced by increasing proportions of women and 
Southern heterosexuals ("Update: Acquired Immunodeficiency 
Syndrome," 1992). AIDS is caused by the human lentiviruses 
Human Immunodeficiency virus (HIV)-1 and HIV-2 (Fauci,
1988). After a variable and often extended incubation 
period, AIDS patients develop clinical signs related to 
either the direct effects of the virus or the induced 
immunodeficiency including persistent lymphadenopathy, 
fever, weight loss, meningoencephalitis, opportunistic 
infections, and secondary cancers (Yarchoan & Pluda, 1988). 
Fifty per cent of all AIDS patients have clinical signs 
related to gastrointestinal dysfunction (Santangelo &
Krejs, 1986). Enteric pathogens, including viruses and 
microorganisms that were variably responsive to specific 
appropriate therapy, have been identified in up to 85% of 
AIDS patients with diarrhea (Smith, 1992). Morphologic and 
functional abnormalities reported in the enteric mucosal 
secretory immune system of AIDS patients have included 
decreased numbers of CD4+ (helper) and increased numbers of 
CD8+ (cytotoxic/suppressor) T lymphocytes in the mucosa 
(Budhraja et al., 1987; Ellankany et al., 1987), decreased
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numbers of plasmacytes staining for IgA (Kotler et al., 
1987), and reduced total IgA in parotid secretions (Muller, 
1991). Reduced systemic immune responses with persistent 
infections by the enteric pathogens, Campylobacter jejuni 
(Perlman et al., 1988), and Giardia lamblia (Janoff, Smith, 
& Blaser, 1988) suggest a functional defect in mucosal 
secretory immunity.
Animal models have been recognized as appropriate ways 
to study the pathogenesis of AIDS because of scientific and 
ethical reasons (Montagnier, 1989). Rhesus monkeys (Macaca 
mulatta) experimentally infected with Simian Immunodefi­
ciency Virus (SIV) develop a disease syndrome more closely 
resembling AIDS than other models (Desrisiers & Ringler,
1989). Reports of studies into other aspects of the 
pathogenesis of SIV infection in rhesus monkeys (Baskin, et 
al., 1988; Baskerville et al., 1990) indicate that 
significant severe gastrointestinal dysfunction occurs 
suggesting the suitability of this model for more specific 
studies of gastrointestinal dysfunction caused by 
immunosuppressive retroviruses.
The aim of this study was to determine if quantitative 
or qualitative differences similar to changes noted in AIDS 
patients occur within cell populations of the enteric 
immune system of M̂ . mulata experimentally infected with SIV 
thus evaluating the usefulness of this model for studies in 
retroviral-induced gastrointestinal dysfunction. A second 
objective was to determine if, after experimental infection
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with the enteric pathogen, C\_ jejuni. the numbers of cells 
within the studied mucosal cell populations changed over 
time differently in mulatta after SIV infection.
Materials and Methods
Animals
Ten male, domestic, corral-reared, clinically normal, 
C. jejuni culture free, rhesus monkeys (NL. mulatta), 1.8 - 
2.5 years old and 2.0 - 3.3 kilogram in weight, were 
randomly assigned into one of two groups of five. None had 
medical histories including evidence of past CL. jejuni 
infection; however, freedom from previous exposure or 
subclinical infection could not be ascertained. Monkeys 
were maintained at the Tulane Regional Primate Research 
Center (TRPRC) in accordance with the Guide for the Care 
and Use of Laboratory Animals. fed a standard prepared 
nonhuman primate diet (Purina Mills, Earth City, MO) 
supplemented with washed assorted fruit, and given water ad 
libitium from the Center's private water system. Monkeys 
were observed daily for signs of illness including 
diarrhea.
Virus Inoculation
One group (SIV) was anesthetized with 10 milligrams 
per kilogram (mg/Kg) ketamine hydrochloride (Fort Dodge 
Laboratories, Fort Dodge, IA) administered intramuscularly 
(IM) and inoculated intravenously in the external saphenous 
vein with approximately 1000 ID5Q of virus contained in one 
milliliter (ml) of cryopreserved, cell free, filtered,
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tissue culture supernatant from human phytohemagglutin- 
stimulated lymphoblast cells infected with SIV/DELTAB670. 
The virus infection was monitored at irregular weekly 
intervals by measuring serum SIV p26 antigenemia using a 
cross-reactive (Zhang, et al., 1988) HIV antigen enzyme 
immunoassay (Abbott Laboratories, North Chicago, IL). 
Bacterial Inoculation
The isolate of Ck. jejuni used to prepare the 
experimental inoculum was obtained from a rectal swab 
culture of a one year old mulatta that died shortly
thereafter from complications of enterocolitis including 
diarrhea and dehydration. Campylobacter jejuni was also 
cultured from the colon at necropsy. The isolate was a 
gram-negative, gull-wing shaped bacteria that was sensitive 
to nalidixic acid, resistant to cephalothin, and hydrolysed 
hippurate. The original isolate was subcultured as a lawn 
on 5% sheep blood agar plates in an atmosphere of 5% 
oxygen, 10% carbon dioxide, and 85% nitrogen at 37°C. After 
48 hours, the growth was scraped from the plate, dispersed 
in sterile tryptic soy broth, and frozen at -70°C in 
sterile tubes containing 15% sterile glycerol.
Because of logistical constraints, only two monkeys 
could be examined endoscopically per day; therefore, to 
maintain a constant postinoculation examination interval, 
only two monkeys could be inoculated with CL. jejuni each of 
the five days of week 0. A fresh batch of CL. jejuni 
inoculum was produced for each of the five days. One ml of
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frozen bacteria was rapidly thawed, subcultured twice as 
described over four days, rinsed from the plates with warm 
phosphate buffered saline (PBS) (pH 7.4) and the suspended 
bacteria standardized for density against a McFarland 
standard by dilution with warm PBS. Previous plate counts 
had determined that there were approximately 3 x 108 c . 
ieiuni per ml in a suspension of the same density as a 
McFarland Standard No. 1 tube. Plate counts were performed 
on the final dilution to more accurately determine the 
number of viable bacteria that had been administered.
A previous study (Murphey-Corb, et al., 1989) found 
that declines in circulating CD4+CD29+ [DBLT4+] 
(memory/helper-inducer) T cells were the best indicator of 
SIV disease progression. Declines had been observed to 
occur as early as 56 days after experimental SIV 
inoculation. Approximately 7 0 days was arbitrarily picked 
as the interval between SIV inoculation and Ck_ ieiuni 
inoculation for this study. At 67 days after SIV 
inoculation, two monkeys, one from each group, were 
inoculated orally with ieiuni. Two additional monkeys, 
one from each group, were inoculated each day over the next 
four days. Monkeys were anesthetized with ketamine 
hydrochloride. Prior to administering the bacterial 
inoculum, 30 ml of an 8.4% sodium bicarbonate (Sanofi 
Animal Health, Inc., Overland Park, KS) solution was 
administered orally via a stomach tube to raise the pH of 
fluids in the stomach to approximately seven to eight.
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• 1 0  . . . .Approximately 3 x 10-*-u CL. ieiuni m  10 ml of PBS were
administered via stomach tube which was flushed with 15 ml 
of PBS. Monkeys were held in an erect position for 10 
minutes to facilitate movement of the fluids into the small 
intestine.
Rectal swabs were cultured at three days, and one, 
two, and four weeks after experimental inoculation to 
determine if colonization of Ck. ieiuni occurred and how 
long colonization persisted. Samples were inoculated onto 
Butzler's medium plates (Luechtefeld, Wang, Blaser, &
Reller, 1981) and incubated at 37°C in an atomosphere of 5% 
oxygen, 10% carbon dioxide, and 85% nitrogen. Gull winged, 
gram-negative spirochetes were subcultured on blood agar 
plates to test for sensitivity to nalidixic acid (Becton- 
Dickinson Microbiological Systems, Cockeysville, M D ) , 
susceptibility to cephalothin (Becton-Dickinson), oxidase 
activity (Marion Scientific, Kansas City, MO), and the 
ability to hydrolyse hippurate (Becton-Dickinson).
Endoscopic Procedures
At one week before (week 0) and 1, 2, and 4 weeks 
after CL. ieiuni inoculation, intestinal biopsies were 
obtained by endoscopy. Sixteen hours before the endoscopic 
procedure, the animal was taken off solid food and given 
35-40 ml/Kg of a polyethylene glycol based bowel cleansing 
agent (Braintree Laboratories, Inc., Braintree, MA) orally.
On the morning of the procedure, the monkey was 
anesthetized with a combination of ketamine hydrochloride,
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acepromazine (0.1 mg/Kg) (Fort Dodge Laboratories), and 
glycopyrolate (0.01 mg/Kg) (Fort Dodge Laboratories) IM.
The colon was further cleansed with a warm water enema. The 
monkey was intubated and anesthesia maintained with 
isoflourane (Anaquest, Madison, WI) at a flow rate of from 
1-2% (Ohio Medical Instruments, Madison, WI) to effect 
administered with humidified oxygen (Saratoga Medical 
Instruments, Hailey, N Y).
An Olympus PQ 20 pediatric endoscope (Olympus Endosco­
py System, Lake Success, NY) with an outside diameter of 9 
mm was passed through the mouth into the duodenum. After 
examination of the mucosa, an alligator-type biopsy forceps 
(Olympus Endoscopy Systems) was placed through the 2.8 mm 
in diameter instrument channel of the endoscope. Using the 
endoscope to visualize the mucosa, four to five, randomly 
selected, full-thickness, mucosal biopsies were snipped 
from the duodenum in an area approximately 2 to 10 cm 
distal to the pylorus. Mucosal biopsies were removed as 
collected, placed in an aluminum foil mold, covered by a 
cryopreservation agent (Lab Tek Products, Naperville, IL), 
aligned, and frozen in a mixture of dry ice submerged in 
acetone.
The endoscope was removed from the upper 
gastrointestinal tract and passed through the anus into the 
colon at approximately the level of the pelvic flexure. As 
in the duodenum, four to five mucosal biopsies were 
collected from randomly selected sites between the pelvic
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and diaphragmatic flexure, removed, and frozen as above. 
Frozen specimens were transported on dry ice and 
transferred into a -70°C freezer for storage.
Staining
The frozen tissues blocks were rotated 90 degrees from 
their orientation during freezing and frozen onto cryostat 
chucks. Seven microns thick cryosections containing 
tangential sections of all four or five of the biopsies in 
the block were cut using a Leitz/Mew Lauda Kryosta 1720 
Digital cryostat (E. Leitz Inc., Rockleigh, NJ). Two 
cryosections of duodenal mucosal biopsies and two 
containing colonic mucosal biopsies from the same monkey 
and date of biopsy were placed near the unfrosted end of a 
3-aminopropyltriethoxy-silane (Sigma Chemical Co., St. 
Louis, MO) coated glass microscope slide (Henderson, 1989) 
labeled with the monkey number and date of biopsy. Multiple 
slides for each monkey (ten monkeys) and date of biopsy 
(four dates) were prepared and combined into sets of 4 0 
slides containing one slide from each monkey for each 
date of biopsy. Enough sets of slides were prepared to 
permit staining of one type of cell per set of slides.
After the slides air dryed, a second party removed the 
monkey numbers and dates and replaced them with a single 
code number preselected from a table of random numbers 
correlateing the monkey number and date of biopsy. The 
slides were placed under vacuum for four hours at 4°C 
before storage in air-tight containers at -20 °C.
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For staining, all slides were brought to room 
temperature under vacuum. To stain immunoglobulin- 
containing cells, a modification of an immunocytochemical 
staining procedure was used (Brigati, et al., 1988). Slides 
were placed in a rack and fixed in a 4% formal-normal 
saline solution (pH 7) for two minutes. After washing in 
distilled water, slides were soaked for 25 minutes in a 
mixture of ethanol:ether::1.5:1 (Curran, & Gregory, 1978). 
After rinsing in absolute ethanol, slides were rinsed in a 
TRIS (Tris[hydroxymethyl]amino-methane)(Sigma Chemical 
Co.)-normal saline buffer (pH 7.5) (Kurec, Baltrucki,
Mason, & Davey, 1988) with 2 ml of fish gelatin (Sigma 
Chemical Co.) per liter of buffer.
Slides were removed from the rack and paired. Care was 
taken to keep the attached tissue moist. On one of the 
pair, a piece of paper tape (American Scientific Products, 
McGaw Park, II) was attached to the frosted end. The slides 
were placed together with the sides bearing the tissues 
facing each other. The tape created a gap which was 
subsequently filled by capillary action with the 
appropriate staining reagents. The slide pairs were 
incubated horizontally in a humidified chamber at room 
temperature.
After pairing, the tissues were incubated for 3 0 
minutes in a 1:66 dilution of normal goat serum (Vector 
Laboratories Inc., Burlingame, CA) in TRIS-saline-gelatin 
buffer containing two grams bovine serum albumin (BSA)
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(Sigma Chemical Co.) added per 100 ml of buffer. The normal 
serum was removed by shaking. One type of cell was stained 
per set of slides. One hundred and fifty microliters (jul) 
of undiluted rabbit anti-human immunoglobulin [IgA, IgG, or 
IgM] (Diagnostic Products Corporation, Los Angeles, CA) 
were applied to each slide pair for two hours. After 
rinsing in TRIS-saline-gelatin buffer, 150 /u 1 of a 1:40 
dilution of biotinylated goat anti-rabbit IgG (Vector 
Laboratories Inc.) in TRIS-saline-gelatin buffer was 
applied for two hours. After rinsing, 150 jtil of the avidin- 
biotin-complex (ABC) reagent (Vector Laboratories Inc.) 
mixed according to the package insert in TRIS-saline- 
gelatin buffer were applied for two hours. Just before the 
end of this period of incubation, a peroxidase, substrate 
solution (Green, Sviland, Malcolm, & Pearson, 1989) 
containing 121 mg of 3,3'-diaminobenzidine (Sigma Chemical 
Co.), 500 /xl of 30% H 202 , and 171 mg of imidiazole (Sigma 
Chemical Co.) in 250 ml of a 0.05 molar (M) TRIS buffer (ph 
7.6) was prepared. The slides were unpaired, reracked, 
rinsed in distilled water, and incubated in the peroxidase 
substrate solution for four minutes in the dark. After 
rinsing in distilled water, the slides were soaked in a 1% 
solution of cobalt chloride (Sigma Chemical Co.) in 0.1 M 
TRIS buffer for four minutes. After rinsing in distilled 
water, the slides were counterstained with Mayer1s 
hematoxylin (Fisher Scientific Co., Fairlawn, NJ) for one 
and one-half minutes. After a tap water rinse, slides were
31
dehydrated in changes of 70% and 95% ethanol (2x) then 
cleared in xylene before coverslipping.
Immunocytochemical staining to identify lymphocyte 
subset cell surface antigens and macrophages was performed 
similarly as for the immunoglobulin-containing cells with 
the following differences. Slides were partially fixed by 
soaking in acetone at room temperature for ten minutes. The 
slides were then rinsed in a TRIS-saline buffer (pH 7.5) 
containing two grams BSA and 0.25 ml of 30% BRIJ 35 (Sigma 
Chemical Co.) per 100 ml buffer. After rinsing, the slides 
were further fixed in a PLP solution (Hall, Stearn, Butler, 
& D'ardenne, 1987) containing 1.42 grams of 1-lysine (Sigma 
Chemical Co.), 225 mgs sodium m-periodate (Sigma Chemical 
Co.), and 75 ml of 3% methanol free formaldehyde 
(Polysciences, Inc., Warrington, PA) in 150 ml of 0.1 M 
disodium hydrogen orthophosphate. After this second 
fixation, slides were rinsed in a 0.15 M PBS buffer, pH 7.5 
(Ringler, Walsh, Mackey, Hunt, & King, 1988), containing 2 
ml fish gelatin per liter of buffer (PBS-gelatin).
Slides were paired and incubated with a 1:66 dilution 
of normal horse or goat serum [CD3+] (Vector Laboratories 
Inc.) for 15 minutes at room temperature. After the normal 
serum was removed by shaking, 150 ill of mouse monoclonal or 
rabbit polyclonal anti-human primary antisera were applied. 
Monoclonal antibodies and dilutions with PBS-gelatin plus 
two grams BSA per 100 ml used were: (neat) anti-human
Leu3a+3b [CD4+, T-helper] (Becton-Dickinson, Mountain View,
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CA); (1:2) anti-human Leu2a [CD8+, T-cytotoxic/suppressor]
(Becton-Dickinson); (1:25) anti-human L25 [B-cell] 
(Dakopatts, Carpenteria, CA); and (1:25) anti-human 
macrophage [CD68, KP1] (Dakopatts). An affinity purified 
polyclonal rabbit anti-human CD3+ [T-cell] (Dakopatts) at a 
1:75 dilution was also used. After rinsing with PBS-gelatin 
buffer, slides were incubated with 150 /xl of 1:40 
biotinylated horse anti-mouse IgG (Vector Laboratories, 
Inc.) in PBS-gelatin buffer with BSA or 1:200 biotinylated 
goat anti-rabbit IgG as appropriate. The remainder of the 
procedures were as above with the appropriate PBS-gelatin 
buffer.
For semiquantitative evaluation of tissue neutrophils 
and mast cells, a chloroacetate esterase procedure (Leder, 
1964) was used. Slides were fixed for two minutes in 
absolute methanol-formalin. Slides were submerged at room 
temperature for 20 minutes in a hydrochloric acid-sodium 
barbital (Sigma Chemical Co.) buffer containing a 
pararosanalin (Sigma Chemical Co.)-sodium nitrite (J.T. 
Baker Chemical Co., Phillipsburg, NJ) solution, N,N- 
dimethly formamide (Sigma Chemical Co.) and napthol AS-D 
chloroactate (Sigma Chemical Co.). After counterstaining 
with hematoxylin, the slides were washed, dehydrated and 
coverslipped.
For semiquantitative evaluation of tissue eosinophils, 
slides were stained using a congo-red based procedure 
(Grouls & Helpap, 1981). Slides were fixed for two minutes
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in absolute methanol-formalin. After air drying, slides 
were stained in Mayer's hematoxylin for two minutes. After
rinsing in 75% ethanol, slides were submerged for 2 0
minutes in a 0.5% congo red-ethanol solution. After rinsing
in ethanol and clearing in xylene, the slides were
coverslipped.
Morphometry
Slides of immunocytochemically stained tissues were 
examined using a Zeiss Axiovert 405 M inverted microscope 
(Carl Zeiss Inc., Thornwood, NY) with 20x or 32x (colonic 
IEL) objectives. The specimen was illuminated with an 
adjustable 12 V 100 watt transilluminator light source. A 
Hamamatsu Model C2400 video camera system (Hamamatsu 
Phototonics K.K., Hamamatsu City, Japan) transmitted the 
image from the microscope to video monitors (Hamamatsu 
Model C2130 and Sony Trinitron PVM-1271Q, Park Ridge, NJ). 
Transmitted images on the monitors were interactively 
connected to a Compaq Deskpro 3 86/20 (Compaq Computer 
Corporation, Houston, TX) microcomputer equipped with a 
mouse. For the types of immunocytochemically stained cells 
to be quantified, the area of the lamina propria minus the 
crypts in the duodenum or colon, the area of the surface 
epithelium in the duodenum (IEL CD8+ cells), or the linear 
distance along the surface epithelium of the colon (IEL 
CD8+ cells) within the computer enhanced field of view were 
measured using a morphometric image analysis software 
program (Analytical Imaging Concepts, Irvine, CA). After
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the area or length was delineated and measured, the 
immunocytochemically stained cells were counted manually.
Cells were identified as immunoglobulin bearing cells 
or macrophages if the nucleus was identifiable and the 
cytoplasm within a clearly defined cell border was stained 
brownish-black (Figure 3.1). Cells were identified as 
having the cell surface marker of interest if all or a 
significant portion of the cell membrane was stained 
brownish-black (Figure 3.2). A total of 12 fields were 
counted from the four to five biopsies of each tissue on a 
slide with the order of biopsy examination determined by 
coin toss.
Statistical Analysis
For each tissue on a slide, areas or lengths and cell 
counts of the 12 fields counted were totaled and an average 
cell count per area of lamina propria (cells/mm2 of lamina 
propria), cell count per area of surface epithelium
n f #(cells/mm of surface epithelium), or cell count per length 
of colonic surface epithelium (cells/centimeter of 
epithelium) was calculated by dividing the total cell count 
by the total area or length. The cell/mm2 calculations were 
subjected to computerized statistical analysis (SAS 
Institute Inc. Cary, NC) using an analysis of variance for 
repeated measures procedure with group (SIV, NEG) and weeks 
after Ĉ _ ieiuni inoculation (0, 1, 2, 4) as variables to 
examine for main effects of the treatments, time, and 
interactions between treatments and time. If unable to
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Figure 3.1. Pho tom icrograph  o f  IgA+ im m unocytochem ica lly  stained (chrom ogen = 
DAB) p lasm acytes  (arrows [not all positive cells m arked]) in the  lam ina propria o f  a 
colonic m ucosal b iopsy  from  rhesus m onkey No. KOI 3 (SIV). Bar = 50 microns.
fit
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Figure 3.2. Photom icrograph  o f  Leu 2a (CD8+) im m unocytochem ica lly  stained 
(chrom ogen = DAB) T  suppressor/cytotoxic  lym phocytes (arrows [not all positive 
cells m arked]) in the  lam ina propria o f  a colonic m ucosal b iopsy from rhesus 
m onkey  N o.K O I3 (NEG). Bar = 5 0  microns.
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reject the null hypothesis that no interaction existed 
between the variables (no week * group effect), the data 
was further subjected to an analysis of variance procedure 
to examine for differences between group means by week. A p 




All five monkeys inoculated with SIV/DELTAB670 became 
infected as demonstrated by finding SIV p26 protein 
activity in serum on SIV postinoculation day 13 using 
immunoassay. The pattern of the antigenemia varied 
considerablely between monkeys (Table 3.1). In all five 
monkeys, there was an initial period of antigenemia first 
observed when first measured at SIV postinoculation day 7 
in two monkeys and by SIV postinoculation day 13 in 
two monkeys when next measured. Antigenemia was first 
detected on SIV postinoculation day 13 when first measured 
in the fifth monkey (K020). This initial period of 
antigeniemia was followed by a variable period when ■ 
immunoassay detected no antigenemia in all five of the 
monkeys.
Antigenemia was not further detected in two of the 
monkeys. One of these monkeys (K020) remains alive at the 
time of this report (30 months). The other (K018) died nine 
months after SIV inoculation from non-gastrointestinal 
complications associated with SIV infection. In the
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Table 3.1 SIV p2 6 Antigenemia in SIV Infected Group
Days P I A K008_______K013______K018_______K020_______K032
0
7 0 .000B 0 . 000 0.934 0.276
13 6.180 0.941 2. 140 0. 699 1. 150
21 0.138 0 . 000 0.000 0 . 000 0 . 000
28 0 . 000 0 . 000 0.000 0 . 000 0 . 000
56 0 . 000 0 . 000 0 . 000 0 . 000 0 . 000
88 1.754 0 . 000 0.000 0 . 000 0 . 000
119 0.000 0 . 000
147 0.147 0.154 0 . 000 0 . 000 0.000
172 0.000
218 0.228 1.234
260 0 . 000 0 . 000 0 . 000
278 0 . 000









488 4 . 610
509 4.490
531 10.380
A. PI = Days after SIV inoculation
B. Values represent nanograms of SIV p26/milliliter serum
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remaining three, antigenemia reappeared at SIV 
postinoculation day 88, 147, or 313, respectively. Once 
antigenemia was redetected, the level of antigen gradually 
increased in two of the three monkeys until death at SIV 
postinoculation day 218 (K013) and 531 (K032). In the 
remaining monkey (K008), the level of the antigenemia 
fluctuated after reappearing until death at SIV 
postinoculation day 218. The level of antigenemia varied 
considerablely at the time of the deaths.
Clinical Findings
No clinical gastrointestinal signs including diarrhea 
were observed in either the SIV-infected (SIV) or not SIV- 
infected (NEG) monkeys during the period of study.
Campylobacter jejuni was recultured from rectal swabs 
taken from 4/5 SIV and 4/5 NEG monkeys at three days, and 
from one of the SIV group again at week 4 after 
inoculation. On postinoculation day 7, gram-negative, gull 
winged, spirochetes morphologically compatible with C . 
jejuni were cultured from two of the SIV group; however, 
subcultures died before identification to the species level 
could be performed.
Endoscopic examination found mild gross changes in 
some of the monkeys in both groups. The changes in one 
monkey from the NEG group included mild pyloric hyperemia 
with a mildly roughened duodenal mucosa. Changes in the SIV 
group included a transient thickened, velvety, large 
colonic mucosa in two monkeys; transient mild, multifocal
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ulceration in one monkey; and transient hyperemia with 
occasional white foci in the pyloric mucosa of another. 
Mucosal lymphocyte subsets
The intensity of immunocytochemical staining varied 
between the anti-human primary antisera used but, as 
indicated in the literature (Ormerod, et al., 1988), all 
resulted in detectable identification by cell type suitable 
for quantitation. Several cell types, B cells, macrophages, 
and IgG-bearing cells were stained by the procedure but 
proved unsuitable for quantification. Very few B cells and 
macrophages that stained with the primary antisera used 
were located in the lamina propria of the duodenum or 
colon. The vast majority were found in or around lymphoid 
nodules or Peyer's patches. Since the collection procedure 
was intentionally random, very few lymphoid nodules were 
available for examination. There was no observable 
difference in the numbers of B cells or macrophages between 
the SIV and NEG groups. Not enough IgG-bearing cells were 
observed in the lamina propria to make quantitative counts 
meaningful. The remaining cell types immunocytochemically 
identified by the appropriate primary antisera were 
quantified and subjected to statistical analysis as 
described.
No statistically significant difference between groups 
(SIV, NEG) was detected for T cells (CD3+)/mm2 of lamina 
propria in either the duodenum or colon nor was a trend 
suggested (Figure 3.3). Both groups considered together did
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F igure  3.3. S catterp lo t graph o f  C D 3+  cells/m m 2 o f  duodenal and  colonic lam ina  p ro p ria  o f  rhesus m onkeys p rev iously  
in fected  (SIV ) o r n o t in fected  (N E G ) w ith  S IV /D elta  B 670 and inocu la ted  o rally  w ith C. ieiuni a t w eek  (0).
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show a statistically significant decrease over time from 
week 0 to week 4 in the duodenum (p = 0.028) but not in the 
colon. Numbers of CD3+ cells/mm of lamina propria were 
similar in the duodenum and colon. In the NEG group, CD3+ 
cells ranged from 343-874 in the duodenum and 364-1063 
cells/mm2 of lamina propria in the colon. In the SIV group, 
CD3+ cells ranged from 319-1399 in the duodenum and 282-839 
cells/mm2 of lamina propria in the colon.
No statistically significant difference between SIV 
and NEG groups was detected for the numbers of T-helper 
(CD4+) lymphocytes/mm2 of lamina propria in either the 
duodenum or colon (Figure 3.4). The analysis of variance 
for repeated measures detected no significant week effect 
or interaction (group * week effect) between the group 
(SIV, NEG) and the ieiuni postinoculation week 0, 1, 2, 
and 4. This indicated no significant compounding effect 
between the SIV and the CU. ieiuni inoculation. An analysis 
of variance was performed to examine for differences 
between group means for each of the four different sampling 
dates (weeks 0, 1, 2, 4). Although values were nearly 
significant for week 4 in the duodenum (p = 0.096), no 
significant differences were detected for any of the weeks. 
The numbers of CD4+ cells/mm2 of the lamina propria were 
similar for the duodenum and colon. In the NEG group, CD4+ 
cells ranged from 190-534 in the duodenum and 130-521 



















Figure 3.4. S catterp lo t g raph  o f  C D 4+ cells/m m 2 o f  lam ina p rop ria  in the duodenum  and co lon  o f  rhesus m onkeys 






CD4+ cells ranged from 252-637 in the duodenum and 186-529 
cells/mm2 of lamina propria of the colon.
Statistically significant increases in numbers of T 
suppressor/cytotoxic (CD8+) cells/mm^ of lamina propria 
were observed in the SIV group compared with the NEG group 
in both the duodenum (p = 0.008) and colon (p = 0.016) 
(Figure 3.5). As for the CD4+ cells, no week effect or 
interaction between group and week were detected indicating 
no significant effect on the CD8+ cell population in the 
mucosa was caused by the Ĉ _ ieiuni and SIV. An analysis of 
variance detected statistically significant increases in 
the mean CD8+ cell numbers of the SIV group for two of the 
four sampling dates in both the duodenum and colon (p <
p ,0.05). There were about equal numbers of CD8+ cells/mm in 
the lamina propria of the duodenums and colons of the NEG 
group; however, the number of CD8+ cells tended to be 
greater in the duodenums of the SIV-infected monkeys than 
in the colons. In the NEG group, CD8+ cells ranged from 
390-717 in the duodenum and 229-833 cells/mm2 of lamina 
propria in the colon. In the SIV group, CD8+ cells ranged 
from 413-1340 in the duodenum and 426-830 cells/mm2 of 
lamina propria in the colon.
No statistically significant difference between SIV 
and NEG groups was detected for the ratio of CD4+/CD8+ 
cells/mm2 of lamina propria in either the duodenum or colon 
(Figure 3.6). As for the CD4+ cells, no week effect or 
interaction between group and week was detected indicating
cells /m m 2 cells/mm2 
NEG 1,600 r—









Figure 3.5. S ca tterp lo t graph o f  C D 8+  ce lls /m m 2 o f  lam ina p ropria  in  the  duodenum  and  colon o f  rhesus m onkeys 
prev iously  in fec ted  (SIV ) or no t in fec ted  (N E G ) w ith SIV /D ELTA  B 670  and  inocu lated  o rally  w ith  C. ieiuni at w eek  0. 
T here  w ere sta tistically  sign ifican t d iffe rences betw een SIV  and N E G  groups (p <  0 .05) in  bo th  the  duodenum  and 
colon. A sterisks iden tify  individual w eeks w hen the re w as a sign ifican t d ifference betw een m ean  C D 8+ cell num bers 
for the S IV  and  N E G  m onkeys (p <  0 .05).
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Figure 3.6. Scatterp lo t g raph  o f  the  ratio  o f  C D 4+ cells/m m 2 o f  lam ina  p ropria :C D 8+  cells/m m 2 o f  lam ina  p ropria  in 
the duodenum  and co lon  o f  rhesus m onkeys in fected  (S IV ) or no t in fected  (N EG ) w ith  SIV /D ELTA  B 670 and 
inoculated  orally  w ith  C. ieiuni at w eek (0).
(J1
46
no significant compounding effect on the CD4+/CD8+ cell 
ratio in the mucosa was caused by the Ch. ieiuni and SIV 
inoculations. An analysis of variance detected a 
statistically significant lower mean CD4+/CD8+ ratio for 
the SIV monkeys only for week 1 in the colon (p = 0.04 9) 
and none in the duodenum. The ratios of CD4+/CD8+ cells in 
the lamina propria were approximately the same in the 
duodenums and colons.
No statistically significant difference between SIV 
and NEG groups was detected for the numbers of IgA+ 
cells/mm2 of lamina propria in either the duodenum or colon 
(Figure 3.7). As for the CD4+ cells, no week effect or 
interaction between group and week were detected indicating 
no significant compounding effect on the IgA+ cell 
population in the mucosa could be attributed to the C . 
ieiuni and SIV inoculations. An analysis of variance 
detected no statistically significant differences between 
group means for any of the sampling dates although there 
was a trend (p = 0.0132) to fewer IgA+ cells in the in the 
colons of the SIV group compared with the NEG group.
Numbers of IgA+ cells/mm2 of lamina propria were 
approximately the same in the duodenums compared with the 
colons although the range was wider in the duodenum. In the 
NEG group, IgA+ cells ranged from 329-1563 in the duodenum 
and 460-1254 cells/mm2 of lamina propria in the colon. In 
the SIV group, IgA+ cells ranged from 543-1382 in the
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F igure  3.7. S ca tte rp lo t g raph  o f  IgA +  cells/m m 2 o f  lam ina p rop ria  in the  duodenum  and  colon o f  rhesus m onkeys 
p rev iously  in fec ted  (S IV ) o r n o t in fected  (N E G ) w ith  SIV /D ELTA  B 670 and  inocu lated  o rally  w ith  C. ieiuni at w eek 
(0). A sterisk  iden tify  ind iv idual w eek  w hen the  m ean  num ber o f  IgA +  cells w ere sign ifican tly  d ifferen t betw een  SIV  






duodenum and 577-1098 cells/mm2 of lamina propria in the 
colon.
Statistically significant increases in the numbers of 
IgM+ cells/mm2 of lamina propria were observed for the SIV 
group compared with the NEG group in both the duodenum (p = 
0.028) and colon (p = 0.012) (Figure 3.8). No week or 
interaction between group and week were detected indicating 
no significant compounding effect in the IgM+ cell 
population of the mucosa could be attributed to the C. 
ieiuni and SIV inoculations. An analysis of variance 
detected statistically significant increased mean IgM+ 
cells (p < 0.05) for the SIV group compared with the NEG 
group for three of the four sampling dates in the colon but 
none in the duodenum. There were about equal numbers of 
IgM+ cells/mm2 in the lamina propria of the duodenums and 
colons of both groups with the increase in the number of 
IgM+ cells slightly greater in the duodenums of the SIV- 
infected monkeys than in the colons. In the NEG group, IgM+ 
cells ranged from 30-135 in the duodenum and 26-123
pcells/mm of lamina propria of the colon. In the SIV group, 
IgM+ cells ranged from 62-211 in the duodenum and 34-148
p , , ,cells/mm of lamina propria m  the colon.
No statistically significant differences between SIV 
and NEG groups were detected for the numbers of IEL CD8+
p fcells/mm of surface epithelium in the duodenum (Figure 
3.9) or IEL CD8+ cells/centimeter of surface epithelium in 
the colon (Figure 3.10). No week or interaction between


















F igure  3.8. S catterp lo t g raph  o f  the IgM +  cells/m m 2o f  lam ina p ropria  o f  the duodenum  and colon o f  rhesus 
m onkeys p rev iously  in fec ted  (SIV ) o r no t in fec ted  (N EG ) w ith  SIV /D ELTA  B 670 and  inocu lated  o rally  w ith  C. 
ieiuni at w eek (0). T he d ifference betw een subjects w as sign ifican t (p <  0 .05) in  bo th  the  duodenum  and  colon. 
A sterisks deno te  w eeks w hen the re  w as a s ign ifican t d ifference in the m ean num ber o f  IgM +  cells betw een the 


















Figure 3.9. S catterp lo t g raph  o f  the  In traepithelia l lym phocytes (IEL) 
C D 8+ cells/m m 2 o f  surface ep ithe lium  in the  duodenum  o f  rhesus 
m onkeys p reviously  in fected  (SIV) or n o t in fec ted  (N EG ) w ith 
SIV/DELTA B 670 and  inocu la ted  orally  w ith  C. ieiuni at w eek (0). 
A sterisk  iden tifies  ind iv idual w eeks w hen the re  w as a  s ign ifican t 












F igure 3.10. Scatterp lo t graph  o f  in traep ithe lia l lym phocy te  (IEL) 
C D 8+ ce lls /cen tim eter o f  co lon ic  surface ep ithe lium  in rhesus 
m onkeys prev iously  in fec ted  (SIV ) or n o t in fec ted  (N EG ) w ith 





group and week were detected indicating no significant 
compounded effect in the IEL CD8+ cell population of the 
mucosa could be attributed to the CL. ieiuni and SIV 
inoculations. An analysis of variance detected a 
statistically significant increase in mean IEL CD8+ cells 
(p = 0.043) for week 0 in the duodenum but not in the 
colon.. IEL CD8+ cells ranged from 295-784 in the NEG group 
and 342-794 cells/mm2 of duodenal surface epithelium in the 
SIV group. IEL CD8+ cells ranged from 46-205 in the NEG 
group and 61-151 cells/centimeter colonic surface 
epithelium in the SIV group.
Neutrophils, eosinophils, and mast cells were assessed 
semiquantitatively in appropriately stained mucosal 
biopsies. Catorgorized grades were 0 = none, 1 = rare, 2 = 
occasional, and 3 = frequent cells in the lamina propria. 
Grades for neutrophils were fairly constant within 
individual monkeys throughout the period of study with most 
having 0 to 1 grades except when the biopsy examined 
included a presumptive previous biopsy site. No difference 
between SIV and NEG groups was appreciated.
Grades for eosinophils were also fairly constant 
within indivdual monkeys but there was more variation among 
monkeys. No differences were noted between SIV and NEG 
groups. Monkeys with increased numbers of eosinophils also 
had increased numbers of nonspecifically stained cells in 
immunocytochemically stained slides. Eosinophil granules 
and to a lesser extent, other granuloctye granules, contain
53
endogenous peroxidase (Li, Ziesmer, Lazcano-Villareal,
1987) that stain nonspecifically with the diaminobenzidine 
substrate. With the stain used, mast cells were rare in all 
monkeys.
Discussion
AIDS, the clinical syndrome that develops after humans 
become infected with HIV-1 or HIV-2, results from a 
combination of direct pathogenic effects of the virus on 
tissues such as the brain and an increased susceptibility 
to infectious diseases which is secondary to an induced 
immunodeficiency. Research into the pathogenesis of the 
immunodeficiency have focused on systemic immunity, yet 
many of the complicating secondary infections assault 
mucosal surfaces including the intestinal tract. Reports 
have described abnormalities in the enteric mucosal cell 
populations of AIDS patients. These cell populations are 
involved in providing specific secretory antibody mediated 
immunity. Infectious agents, including enteric bacteria 
thought to be controlled by specific antibody mediated 
immunity, associated with gastrointestinal dysfunction, are 
frequently identified in AIDS patients indicating the 
immunodeficiency caused by HIV infection extends to affect 
secretory immunity.
The availibility of an animal model would facilitate 
research into the pathogenesis of the changes observed in 
the AIDS patients by allowing controlled experimental 
studies, not possible for ethical or moral reasons on
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humans. The SIV-infected, rhesus monkey model, such as the 
one developed at the TRPRC, has been demonstrated to be an 
excellent animal model for studying many aspects of AIDS 
pathogenesis; however, few studies of the effects of SIV on 
the secretory immune system have been reported. One report 
described changes in the cell populations of the 
reproductive tract mucosa of SIV-infected rhesus monkeys 
(Miller, et al., 1992), another area where secretory 
immunity is important, but did not include examination of 
the gastrointestinal tract. Very rare IgA or IgG and small 
numbers of plasmacytes observed in the reproductive tract 
of SIV monkeys suggested to the authors that the mucosal 
immune system was impaired.
The results of studies described in this chapter 
document changes in the cell populations of the enteric 
mucosa of SIV macaques similar to those observed in AIDS 
patients. The number of CD8+ cells/mm2 was increased in the 
SIV monkeys as in AIDS patients. Others (Budhraja, et al., 
1987; Ellakany, et al., 1987) have theorized that these 
cells are T cytotoxic cells recruited to eliminate virally 
infected cells, T suppressor cells which may be suppressing 
the T helper population from augmenting antibody 
production, or T suppressor cells suppressing T cytoxic 
cell function as explanations of the increased 
susceptibility to infectious agents. The availability of 
the animal model should allow the harvest of adequate 
numbers of cells to determine functional status of the
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various populations and changes in functional capabilities 
change over the course of retrovirus infection.
Although studies of AIDS patients showed decreased 
CD4+ cells/unit area compared with controls, the numbers 
varied in relation to the number of CD8+ cells/unit area. 
Since the methods of quantification varied in the studies 
of AIDS patients, results were reported in different units 
between studies. Thus, direct comparisions of cell numbers 
among studies of AIDS patients or among studies of AIDS 
patients and these SIV monkeys was not possible. In two 
studies of AIDS patients (Ellakany, et al., 1987; Rogers, 
et al., 1986), the number of CD4+ cells/unit area was 
greater than the number of CD8+ cells/unit area in normal 
controls (CD4+/CD8+ > 1) but less than the number of CD8+ 
cells/unit area in AIDS patients (CD4+/CD8+ < 1). In 
another study (Budhraja, et al., 1987), the number of CD4+ 
cells/unit area was less than the CD8+ cells/unit area in 
normal controls (CD4+/CD8+ < 1) and decreased even more in 
AIDS patients.
In contrast to the results for AIDS patients, CD4+ 
cells in the mucosa of SIV monkeys were not significantly 
decreased statistically compared with NEG monkeys. The 
number of CD4+ cells/unit area was less than the number of 
CD8+ cells/unit area (CD4+/CD8+ < 1). Because the number of 
cells/unit area cannot be directly compared and the results 
from the AIDS patients studies vary, determination of 
whether there are normally fewer CD4+ cells or more CD8+
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cells/unit area of enteric mucosa in monkeys compared with 
humans could not be deterimined. In another study using 
single cell suspensions of lymph nodes (Rosenberg, et al., 
1992), there were more CD4+ cells than CD8+ cells, but no 
decrease in CD4+ cells was observed until the circulating 
CD4+/CD8+ ratio was less than 0.5. None of the SIV monkeys 
in this study had circulating CD4+/CD8+ ratios consistently 
below 0.5.
Since the decrease in the CD4+ cell population was 
considered important in the pathogenesis of the increased 
susceptibility to infectious agents in AIDS patients, 
further studies are needed to directly compare the numbers 
of mucosal CD4+ and CD8+ cells in this model to human 
numbers.
Campylobacter ieiuni was selected as the enteric 
pathogenic agent for use in these studies. Previous reports 
described infections with this bacterium in both AIDS 
patients and SIV infected rhesus monkeys. Development of a 
specific IgA secretory and systemic antibody response are 
thought to be important in recovery from and resistance to 
campylobacteriosis, thus implying an increase in at least 
the number of anti-C. ieiuni IgA+ cells and possibly other 
types of cells in the mucosa after exposure. An analysis of 
variance for repeated measures procedure did not indicate 
that the inoculation of Ch. ieiuni increased the specific 
anti-C. ieiuni IgA cells enough to significantly change the 
total number of IgA+ cells over the period of study and
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that the differences observed were more appropriately 
attributed to SIV-induced changes. Efforts to stain 
specific anti-C. ieiuni IgA+ cells for a morphometric 
analytical comparision between SIV and NEG monkeys as had 
been described for other antigens (Schmucker, Daniels,
Wang, & Smith, 1988) were unsuccessful. Based on the 
results from this study, further studies are recommended to 
examine whether there are changes in cell numbers of the 
various types of cells involved in the immune response and 
whether there are associated functional deficits.
There were significantly increased numbers of IgM+ 
cells in the mucosa. This finding was also noted in AIDS 
patients and homosexuals versus heterosexual controls in 
one study (Kotler, et al., 1987). The authors speculated 
that since the change was present in the homosexual group 
as well as AIDS patients then some enviromental factor 
might be involved. The time of the study and lack of 
mention of the HIV-1 antibody suggest that some of the 
homosexual group may have been HIV-1 infected. Lymphokines 
secreted from T helper cells are involved in 
differentiation of IgM- to IgA-bearing cells. Although CD4+ 
cells were not decreased, SIV infection may have resulted 
in functional changes such as decreased availability of 
these differentiation-facilitating cytokines.
Seventy days was arbitrarily selected as the interval 
between the SIV and ieiuni inoculations. Changes in the 
population of circulating CD4+CD29+ T memory/helper-inducer
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cells, thought to be important in monitoring the progress 
of the infection, had been noted in other reports as early 
as 56 days after virus infection. The interval selected was 
thought to be long enough for the changes in cell 
populations to occur without allowing the SIV monkeys to 
become sufficiently immunosuppressed that the anticipated 
clinical campylobacteriosis would prove fatal during the 
study. In retrospect the concern about severe clinical 
disease proved unfounded. The interval still proved to be 
adequate to permit statistical changes to occur in the SIV 
monkeys thereby indicating the usefulness of the model. 
Longer intervals might have permitted trends seen in some 
of the cell populations, such as IgA+ cells, to increase to 
statistical significance.
The length of colonization by Ch. ieiuni was assessed 
by attempting to reculture the bacteria from rectal swabs 
at intervals after experimental inoculation. Campylobacter 
ieiuni was cultured from 8/10 monkeys on postinoculation 
day 3 indicated that the experimental inoculation process 
successfully induced colonization of the intestine by the 
bacteria. One of the remaining two, a SIV monkey, was 
culture positive for a campylobacter on postinoculation day 
7. The reason Ch_ ieiuni was not cultured from the remaining 
monkey, a NEG monkey, was not determined. Two SIV monkeys 
on week 1 had a campylobacter-like bacteria cultured that 
died before identification to the species level could be 
accomplished. Since the morphology was similar and the
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monkeys had been inoculated recently with a C\. ieiuni. the 
bacteria isolated were assumed to be CL_ ieiuni. 
Interestingly, the SIV monkey (K008) from which a CL. ieiuni 
was cultured at week 4, also assumed to be the same 
bacteria as the experimental inoculum, was the monkey with 
the lowest numbers of IgA+ cells in the colonic mucosa.
No statistically significant differences were observed 
between SIV and NEG groups for numbers of CD3+ cells and 
IEL CD8+ cells. These findings are similar to results from 
AIDS patients studies.
The endoscopic procedures proved to be fairly inocuous 
minor procedures with no adverse effects to the monkeys or 
to the experimental results with the exception of 
occassionally increasing the numbers of neutrophils in a 
biopsy. These areas were easily recognizable and did not 
interfere with morphologic analysis.
The immunocytochemical staining process required 
various manipulations of the procedures to achieve staining 
of the different cell types. Different fixatives and 
buffers were required for cell surface markers than for the 
immunoglobulin-containing cells. In order to stain all of 
the slides for a particular marker on one run, which was 
done to insure uniformity of staining, refreezing of the 
slides bearing the cryosections was necessary. This had a 
deleterious effect on the staining of the IgA slides.
Adding the ether:ethanol step resulted in unmasking of the 
IgA in the sections and successful staining.
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The patterns of antigenemia varied in the SIV monkeys 
as has been previously reported (Zang, et al., 1988). Death 
occurred in one SIV monkey (K018) without the reappearance 
of antigenemia after SIV postinoculation day 13. No 
consistent correlations between numbers of mucosal CD4+ or 
CD8+ cells emerged in relation to the time of reappearance 
or level of antigenemia. The only monkey (K008) that had an 
antigenemia during the period of the Cj_ ieiuni study and 
was the second monkey to die had the lowest numbers of IgA+ 
cells in the mucosa.
One of the SIV monkeys (K020) remains alive 30 months 
after SIV inoculation at the time of this report. Two 
monkeys died within seven months of SIV inoculation. One, 
(K008) which was persistently infected with Ĉ _ ieiuni 
during the period of the study, was also positive when 
cultured for clinical reasons four months after 
experimental inoculation. This may or may not have been the 
same bacteria as the experimental inoculum. Death was 
attributed to a malignant lymphoma in the heart and 
cryptosporidiosis. In the second (K013), death was 
attributed to cryptosporidiosis. Campylobacter ieiuni was 
not cultured after postinoculation day 7.
The other two SIV monkeys were placed on a second 
study unrelated to campylobacteriosis eight months after 
SIV inoculation. Neither were culture positive for C. 
ieiuni after postinoculation day 3. One (K018) died nine 
months after SIV inoculation with a mesenteric lympyhoma
and thrombosis of the cerebral vasculature. The second 
(K032) died seventeen months after SIV inoculation with 
death attributed to generalized adenovirus infection.
CHAPTER 4
Altered Secretory and Systemic Antibody Responses to 
Campylobacter jejuni in Macaques Infected with SIV: 
Correlation with Circulating and Mucosal 
Immune System Cell Populations
Introduction
Defense of mucosal surfaces against degradation by a 
variety of toxins and infectious agents is provided by 
nonspecific factors, such as, motility, extreme variations 
in pH, mucinous coating, enzymes, and antigen-specific 
factors, such as antibodies, which recognize at the 
molecular level before effecting removal or destruction 
(McNabb & Tomasi, 1981). Immunoglobulin A (IgA) is the 
predominant immunoglobulin in mucosal secretions with 
functional activities including neutralization of toxins 
and viruses, blocking adhesion of bacteria to epithelial 
cells, opsonization, antibody-dependent cellular 
cytotoxicity, and enhancement of nonspecific factors 
(Goldblum, 1990). The prominent role of IgA in protecting 
mucosal surfaces is suggested by the increased 
susceptibility to enteric viruses (Lonsonsky et al., 1985), 
protozoa (Ament & Rubin, 1972) and bacteria such as 
Campylobacter jejuni (Ahnen & Brown, 1982; Melamed et al., 
1983) in humans with IgA or combined immunodeficiencies.
Research has also indicated the importance of IgA in 
mucosal resistance to Ch. jejuni. Anti-campylobacter 
intestinal and serum IgA, which developed after the initial 
challenge with C_;_ jejuni. were found to be the best
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predictors of resistance to recolonization in rabbits after 
rechallenge with the same strain of bacteria (Burr et al., 
1988). After rechallenge, the bacteria could only be 
recultured for 2-3 days in rabbits with specific intestinal 
and serum anti-campylobacter antibody versus two to three 
weeks after the initial challenge. In an epidemiological 
study of campylobacteriosis in Bangladeshi children, an age 
related increase in serum IgA was observed to correlate 
with acquisition of protective immunity and was thought to 
represent development of a specific, secretory IgA response 
(Blaser et al., 1985). Human volunteers inoculated with 
different strains of CL. jejuni (Black et al., 1988) 
developed serum antibody responses which protected all from 
illness; but, resistance to reinfection by the same strain 
after rechallenge varied with the strain used.
AIDS patients have an inability to mount serologic 
responses to new antigens and a highly variable response to 
recall antigens (Lane, 1984). Persistent jejuni enteric 
and systemic infections have been reported (Perlman et al.,
1988) in AIDS patients which had abnormally low anti- 
campylobacter systemic antibody responses when compared 
with non-AIDS patients with campylobacteriosis. Reported 
morphologic alterations in the cell populations of the 
enteric mucosal immune system, include depletion of CD4+ 
and increased CD8+ T lymphocytes (Budhraja, et al., 1987) 
and decreased numbers of IgA plasmacytes (Kotler, 
et al., 1987) which suggests diminished mucosal immune
64
response, but further study of the mucosal immune response 
is needed.
The need to use animal models for scientific and moral 
reasons has been advocated (Montagnier, 1989). The SIV- 
infected rhesus monkey has been described as the most 
appropriate animal model of AIDS because of similarities in 
the viruses, the clinical course, and the immunologic 
abnormalities observed (Desrosiers & Ringler, 1989).
Reports from several general pathogenesis studies (Baskins 
et al., 1988; Baskerville et al., 1990) indicate 
that, as in AIDS patients, SIV-infected rhesus monkeys 
frequently develop gastrointestinal dysfunction associated 
with C_j_ jejuni infection. This suggests that in both AIDS 
patients and SIV-infected macaques, the immunodeficiency 
produced by the retroviruses may extend to the enteric 
mucosal immune system and lead to increased rates of 
infections by enteric pathogens.
Therefore the objectives of this study were to examine 
whether SIV infection of rhesus monkeys resulted in a 
decreased specific immunoglobulin response to an enteric 
bacterial pathogen, jejuni. and how this affected the 
course or severity of the infection.
Materials and Methods
Animals
Ten male, domestic, corral-reared, clinically normal,
C. jejuni culture-free, rhesus monkeys (Macaca mulatta),
1.8 to 2.5 years old and 2.0 to 3.3 kilogram in weight,
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were randomly assigned to one of two groups of five 
monkeys. Examination of medical histories found no evidence 
of past C_i. ieiuni infection. Monkeys were fed a standard, 
commercial, nonhuman primate diet supplemented with washed 
assorted fruit and given water ad libitium.
Virus Inoculation
The group of monkeys to be inoculated with SIV were 
anesthetized with ketamine hydrochloride. Each monkey was 
inoculated intravenously with approximately 1000 ID50 of 
SIV/DELTAggyq . The virus infection was monitored by 
measuring serum antigenemia at irregular weekly intervals 
using a commercial enzyme immunoassay.
Bacterial Culture and Inoculation
The isolate of ieiuni used was obtained from a one 
year old 1YL_ mulatta that died from complications of 
enterocolitis. After isolation, subculturing was performed 
on 5% sheep blood agar plates in an atmosphere of 5% 
oxygen, 10% carbon dioxide, and 85% nitrogen at 37°C. 
Subcultures were frozen in tryptic soy broth containing 15% 
sterile glycerol at -7 0°C prior to use.
A fresh Cj_ ieiuni inoculum was produced for each of 
the five inoculation days. One ml of frozen bacteria was 
rapidly thawed, subcultured twice over four days, rinsed 
from the plates with warm PBS and the suspended bacteria 
standardized for density against a McFarland standard by 
dilution with warm PBS. Plate counts were performed on the
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inoculum to determine the number of viable bacteria 
administered.
Based on the results of an earlier study, 
approximately 7 0 days was arbitrarily picked as the 
interval between SIV inoculation and Ĉ _ ieiuni inoculation 
for this study. Monkeys were anesthetized with ketamine 
hydrochloride and given 30 ml of an 8.4% sodium bicarbonate
solution orally to neutralize the pH of the stomach.
. in . . . .Approximately 3 x 10 C\_ ieiuni in 10 ml of PBS were
administered via a stomach tube.
Rectal swabs were cultured for C\_ ieiuni at three 
days, and one, two, and four weeks after experimental 
inoculation on Butzler's medium at 37°C in an atmosphere of 
5% oxygen, 10% carbon dioxide, and 85% nitrogen.
Clinical examination
Monkeys were observed daily for signs of illness 
including diarrhea. Physical examinations were conducted 
weekly to bi-weekly from the time of SIV inoculation. 
Physical examinations included a general examination with 
particular emphasis on the status of lymphoid organ size. 
Samples for hematology were collected at the time of these 
exams and irregularly for clinical chemistries. Automated 
hematology (Coulter Electronics, Inc., Hialeah, FL) 
measured hematocrit, total white blood cell, and platelet 
count. Differential white blood cell counts including 
neutrophils and lymphocytes were performed manually. 
Automated clinical chemistries (Beckman Instruments, Inc.,
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Brea, CA) were performed on some of the samples and 
measured total protein, albumin, globulin, alanine 
aminotransferase, asparate aminotransferase, blood urea 
nitrogen, alkaline phosphatase, and gamma- 
glutamyltranspeptidase.
Endoscopic Procedures
At one week before (week 0) and one, two, and four 
weeks after ieiuni inoculation, intestinal biopsies and 
samples of both small and large intestinal contents were 
obtained. Sixteen hours before the endoscopic procedure, 
the animal was taken off solid food and given a colonic 
cleansing agent orally. On the morning of the procedure, 
the monkeys were anesthetized with ketamine hydrochloride, 
acepromazine and glycopyrolate. The colon was further 
cleansed with a warm water enema. Anesthesia was maintained 
with a mixture of isoflourane and oxygen.
An endoscope was passed to the duodenum. A 2.6 mm 
outside-diameter, 1.8 mm inside-diameter, hollow, tygon 
plastic catheter (Olympus Endoscopy Systems) was passed 
through the instrument channel and available duodenal 
contents in amounts from 0.8 to 2.5 ml was aspirated and 
collected. The catheter was removed and replaced with an 
alligator-jawed biopsy tool. Four to five, full-thickness, 
mucosal biopsies were collected. Mucosal biopsies were 
aligned in a mold within a cryopreservation agent and 
quickly frozen in a mixture of dry ice and acetone.
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The endoscope was removed from the upper 
gastrointestinal tract and passed into the colon at 
approximately the level of the pelvic flexure. As in the 
duodenum, from 10 to 15 ml of colonic contents were 
aspirated and collected. Four to five mucosal biopsies were 
collected from various sites, removed, and frozen as above.
The colonic contents were filtered through gauze to 
remove larger pieces of fecal material then centrifuged at 
1200 x gravity (g) for 10 minutes. These supernatants of 
colonic contents and the duodenal contents were 
subsequently processed in a similar manner (Gaspari, 
Brennan, Solomon, & Elson, 1988) to prevent digestive and 
bacterial enzymatic degradation of IgA. Volumes of soybean 
trypsin inhibitor (Sigma Chemical Co., St. Louis, MO) at 
one mg/ml in PBS equal to 10% of the contents volume and 
1.0 M ethylenediaminetretraacetic acid [EDTA] (Sigma 
Chemical Co.) in PBS equal to 5% of the contents volume 
were added to the contents, mixed, and centrifuged at 550 x 
g for 10 minutes. To the resultant supernatant, 100 mM 
phenylmethylsulfonyl fluoride [PMSF] (Sigma Chemical Co.) 
in 95% ethanol equal to 1% of the new volume was added, 
mixed and centrifuged at 2 2 00 x g for 3 0 minutes. To the 
resultant supernatant, 100 mM PMSF in 95% ethanol equal to 
1% of the new volume and sodium azide at 2 0 mg/ml (Sigma 
Chemical Co.) in PBS equal to 1% of the new volume were 
added and mixed. Fifteen minutes later, heat-inactivated 
calf serum (Sigma Chemical Co.) equal to 4% of the new
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volume was added and mixed. These processed contents were 
dispensed into gasketed screw-top vials and placed directly 
on dry ice for freezing.
Blood collected at the times of the endoscopic 
procedures was centrifuged at 1200 x g yielding 1 to 2 ml 
of serum. Serum was dispensed into the gasketed vials and 
frozen on dry ice as above.
Frozen specimens were transported on dry ice and 
transferred into a -70°C freezer for storage.
ELISA Methodology
Titers of specific anti-C. ieiuni IgA and IgG and 
total IgA and IgG in both serum and processed intestinal 
fluids were evaluated using modified indirect microplate 
enzyme-linked immunosorbent assay (ELISA) techniques 
(Coligan, Kruisbeek, Margulies, Shevach, & Strober, 1991).
For specific anti-C. ieiuni antibody assays, the same 
C. ieiuni isolate used to experimentally inoculate the 
monkeys was used for production of the solid-phase reagent 
in the assays. A rapidly thawed frozen subculture of the C . 
ieiuni in tryptic soy broth was spread over the surfaces of 
Mueller-Hinton agar (Difco Laboratories, Detroit, MI) 
plates and cultured for 48 hours in an atmosphere of 5% 
oxygen, 10% carbon dioxide, and 85% nitrogen at 37°C. After 
48 hours, the bacterial lawn was washed from the plate with 
sterile PBS. The bacterial suspension was centrifuged at 
6000 x g for five minutes. The bacteria were washed two 
more times by suspension in fresh sterile PBS and
70
centrifuged at 6000 x g for 10 minutes. The bacteria were 
then prepared for sonication (Harlow, & Lane, 1988) by 
suspending them in a lysis buffer (pH 8.0) containing 150 
mM sodium chloride, 1% polyoxyethylene (9) p-t-octyl phenol 
[NP-40], 0.5% sodium deoxycholate [DOC], 50 mM TRIS (Sigma 
Chemical Co.), and 1% sodium dodecysulfate [SDS] (Pierce 
Chemical Co., Rockford, IL). The bacterial suspension was 
placed in an ice water bath and sonicated (Model W-375,
Heat Systems-Ultrasonics, Inc., Plainview, NY) using five,
3 0 seconds bursts at full power. After sonication, the 
bacteria were centrifuged at 100,000 x g for 10 minutes. 
Using a modification of the Lowery procedure (Markham,
Hass, Bieber, & Tolbert, 1978) the total protein content of 
the sonicate was determined to be approximately 675 jiig/ml 
of solution. The supernatant was dispensed into gasketed- 
screw cap tubes and frozen at -7 0°C until use.
For assay of serum 200 jul, polyvinyl, 96-well plates 
(Costar, Cambridge, MA) plates were incubated overnight at 
4°C with 100 fj, 1 carbonate buffer (pH 9.6) containing 1 jug 
of protein/ml of the CL. ieiuni sonicate. The plates were 
washed in a PBS buffer (pH 7.4) containing 0.005% 
polyoxyethylene-20-sorbitan monolaurate [Tween 20]
(Amresco, Solon, OH). The plates were washed three times by 
filling the wells with the wash buffer, rotating the plates 
on a rotator (Hoefer Sceintific Instruments, San Francisco, 
CA) for five minutes, and batting the plates to remove wash 
fluids. The plates were incubated at room temperature for
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three hours with 100 jul coating buffer/well of PBS (pH 7.4) 
containing 2% fish gelatin, 1% normal goat serum, and 0.05% 
Tween 20. After batting dry without washing, wells were 
incubated for two hours at room temperature with serial 
doubling dilutions of a 1:10 dilution of serum 
(triplicates) diluted with PBS-gelatin-Tween (0.05%) 
buffer. Plates were washed as above and wells were 
incubated with 100 jj.1 of a 1:2000 dilution of goat, anti­
human, IgG-alkaline phosphatase conjugate (Sigma Chemical 
Co.) or a 1:2000 dilution of goat anti-human, IgA-alkaline 
phosphatase conjugate (Organon Teknika Corp., Durham, NC) 
in PBS-gelatin-Tween (0.05%) buffer at room temperature. 
Plates were washed five times as above and wells were 
incubated for 3 0 (IgG) or 4 0 minutes (IgA), in the dark, at 
room temperature with 100 ill of one mg/ml p-nitrophenyl 
phosphate, disodium substrate in diethanolamine buffer (pH 
9.8) (Sigma Chemical Co.). The reactions were stopped with 
50 Hi of 3M sodium hydroxide. Control samples assayed ran 
concurrently included wells without serum or secondary 
antibody-conjugate, substrate only, human IgA from 
colostrum (Sigma Chemical Co.), serum from a rhesus monkey 
convalescing from a clinical case of campylobacteriosis, 
and serum from the same monkey that had been absorbed 
against C^ ieiuni sonicate.
For total immunoglobulins, 96-well plates were 
incubated overnight at 4°C with 100 fil of carbonate buffer 
(pH 9.6) containing 2.5 /zg/ml of goat anti-human IgA
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antiserum or goat anti-human IgG antiserum (Sigma Chemical 
Co.)* Wash procedures and coating, wash, and diluent 
buffers were the same as those used above. One hundred n1 
of serial doubling dilutions of serum from weeks 0 and 4 
starting with 1:50 were incubated in wells (doublets) 
overnight at 4°C. After washing, 100 /xl of 1:5,000 anti­
human IgG-alkaline phosphatase conjugate (Organon Teknika 
Corp., Durham, NC) or 1:4,000 anti-human IgA-alkaline 
phosphatase conjugate (Organon Teknika Corp., Durham, NC) 
was incubated in the wells overnight at 4°C. After washing, 
the wells were incubated with the substrate buffer as above 
at room temperature for 3 0 (IgG) or 4 0 (IgA) minutes in the 
dark. The reaction was stopped with 3M sodium hydroxide. 
Controls assayed concurrently included wells without serum, 
without secondary antibody-conjugate, substrate only, human 
IgA from colostrum (Sigma Chemical Co.), or human IgG 
(Sigma Chemical Co.).
Assay of intestinal fluids for specific anti-C. jejuni 
IgA, nonspecific binding of IgA and total intestinal 
contents IgA-units were conducted simultaneously. 
Preliminary studies found variable levels of nonspecific 
reactivity with the secondary anti-IgA antibody among 
intestinal contents samples assayed in plates coated with 
coating buffer, but not Campylobacter antigens. The causes 
of the nonspecific activity were thought to be either 
constituents of intestinal secretions, such as mucins, or 
food materials coated with IgA that bound to the plate.
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Nonspecific binding was assayed for each sample to permit 
adjustment of the optical density (OD) of specific anti-C. 
ieiuni assays.
The level of total IgA activity in each sample was 
used to adjust for relative differences in sample water 
content. Because of differences in the affinities for human 
and M_;_ mulatta IgA by the goat anti-human IgA antiserum 
used as a reagent in preliminary assays, IgA activity was 
estimated in IgA-units. The concentration of IgA-units in a 
sample was estimated by comparing the measured OD of the 
sample with the graph of a standard curve created by 
measuring the OD of known concentrations of human IgA.
The assays of intestinal contents were conducted in a 
similar manner as for the comparable serum assays with the 
following differences. Since Tween 20 or other detergents 
have been observed to interfere with assays of intestinal 
fluids (Gaspari, Brennan, Solomon, & Elson, 1988), buffers 
for plate washing and reagent dilution were PBS or PBS- 
gelatin without Tween 20, respectively. Serial doubling 
dilutions of intestinal fluids started at a dilution of 1:2 
with buffer. For nonspecific binding of IgA, dilutions of 
intestinal fluids were assayed in wells of plates that had 
been incubated with coating buffer only and not sonicated 
C . ieiuni. Total IgA-units in intestinal contents and human 
IgA standards were assayed in wells that had been incubated 
overnight at 4°C with 100 ju 1/well of carbonate buffer (pH 
9.6) containing 2.5 ng/ml of goat anti-human IgA. Human IgA
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was measured in serial doubling dilutions in concentrations 
beginning with 500 ng/ml. Controls for anti-C. ieiuni IgA 
and total IgA as described above were also run 
concurrently.
The OD of the developed substrate containing fluid in 
the wells of all of the plates was measured at a wavelength 
of 4 05 nanometers with an automated ELISA plate reader 
(Dynatech Laboratories, Alexandria, V A ) . The reader was 
blanked using a well containing PBS buffer. Endpoint titers 
for serum were determined (Formal, et al., 1984) as the 
highest dilution of serum where the OD of the median well 
(triplicates) or the average of the OD of the wells 
(doublets) exceeded a predetermined minimal limit. The 
minimum value was set to exceed the highest optical 
densities observed in control wells. The minimum OD for 
serum total IgG was 0.200, for serum total IgA was 0.200, 
serum anti-C. jejuni IgG was 0.2 00 and serum anti-C. jejuni 
IgA was 0.100.
To compare the levels of anti-C. jejuni IgA activity 
in intestinal contents between different sampling dates and 
monkeys, adjustments to the measured OD were performed to 
attempt to account for differences in nonspecific binding 
and the relative total IgA-units concentrations among 
samples. The OD of the nonspecific binding measured at the 
same dilution of intestinal contents was subtracted from 
the anti-C. jejuni OD. Using the total IgA-units 
concentrations, a separate IgA-units concentration average
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was calculated for all colonic or duodenal samples. A 
numerical factor was calculated for each sample that would 
mathematically equalize each sample to the same IgA-units 
concentration. The corresponding anti-C. ieiuni OD minus 
the nonspecific OD was then multiplied by this numerical 
factor to mathematically estimate the anti-C. ieiuni OD 
reflecting the equalized total IgA-units concentration. The 
minimum OD limit for defining the end-point titer dilution 
was 0.200.
Lymphocyte subset analysis
Lymphocyte subset analysis was performed on blood 
samples collected in ethylenediaminetraacetic acid (EDTA) 
containing tubes (Becton-Dickenson, Rutherford, NJ) at 
irregular intervals after SIV inoculation. For analysis, 
cells were stained by mixing 50 jul of blood with antibody- 
conjugate and incubating for 30 minutes at 32°C. Red blood 
cells were lysed and the remaining stained mononuclear 
cells fixed (Coulter Cytometry, Hialeah, FL). Two-color 
flow cytometry analysis was performed using an EPICS 541 
(Coulter Cytometry) fluorescent antibody cell sorter. Cells 
were labeled with individual or a combination of 
flourochrome-conjugated cross-reactive anti-human 
monoclonal antibodies (Martin, et al., 1985). Monoclonal 
antibodies reactive against CD2+ T-cells [phycoerythrin- 
Tll] (Coulter Immunology, Hialeah, FL), CD4+ T-helper cells 
[fluorescein-OKT4] (Ortho Diagnostics, Raritan, NJ), CD8+ 
T-suppressor/cytotoxic cells [phycoerythrin-Leu-2a]
(Becton-Dickinson, Mountain View, CA), CD20+ B-cells 
[fluorescein-Bl] (Coulter Cytometry), and CD4+/CD29+ T- 
memory/helper-inducer cells [fluorescein-0KT4+] + 
phycoerythrin-4B4 (Coulter Cytometry)] were used for 
staining. Except for CD4+CD29+ cells, results were 
expressed in percentages of cells stained based on counts 
of 5000 blood mononuclear cells. The CD4+CD29+ cells were 
expressed as a percentage of CD4+ cells. Relative absolute 
numbers of all subsets were calculated based on 
concurrently determined total lymphocyte counts.
Stains
Seven micron cryosections containing tangential 
sections of all four or five of the biopsies from both 
duodenum and colon were placed on a coded microscope slide. 
After air drying and storage under vacuum for four hours at 
4°C, slides were stored in air-tight containers at -20°C.
Prior to staining, all slides were brought to room 
temperature under vacumn. For histopathologic examination, 
slides were stained with hematoxylin and eosin. Slides were 
fixed in 10% formalin in 80% ethanol. After rinsing in 
distilled water, they were submerged in Gill's hematoxylin 
(Fisher Scientific Co., Fairlawn, NJ) for one minute. After 
rinsing in tap water and 80% ethanol, they were submerged 
in eosin (MCB Manufacturing Chemists, Inc., Gibbstown, NJ) - 
phloxine (Fisher Scientific Co.) for 30 seconds. After 
dehydration in alcohol and clearing in xylene they were 
coversliped.
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For staining of mucosal IgA-bearing cells, slides were 
fixed in a 4% formalin-normal saline solution. After a 
distilled water rinse, slides were soaked in a mixture of 
ethanol:ether::1.5:1. After rinsing in absolute ethanol, 
slides were rinsed in a TRIS-normal saline buffer (pH 7.5) 
with 2% fish gelatin.
Slides were paired. On one of the pair, a piece of 
paper tape was attached to the frosted end. The slides were 
placed together with the sides bearing the tissues facing 
each other. After pairing, the tissues were incubated at 
room temperature for 3 0 minutes in a 1:66 dilution of 
normal goat serum in TRIS-saline-gelatin buffer with added 
BSA placed in the gap between slides. The normal serum was 
removed by shaking. The slide pair was next incubated with 
rabbit anti-human IgA for two hours. After rinsing in TRIS- 
saline-gelatin buffer, the slides were incubated with a 
1:40 dilution of biotinylated goat anti-rabbit IgG in TRIS- 
saline-gelatin buffer for two hours. After rinsing, an 
avidin-biotin-complex reagent in TRIS-saline-gelatin buffer 
was applied for two hours. After the slides were unpaired, 
reracked, and rinsed in distilled water, they were 
incubated for four minutes in the dark in a peroxidase- 
diaminobenzidine substrate solution. After rinsing in 
distilled water, the slides were soaked in a 1% solution of 
cobalt chloride in 0.1 M TRIS buffer for four minutes, 
counterstained with Mayer's hematoxylin for one and one-
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half minutes, dehydrated in ethanol, cleared in xylene, and 
coverslipped.
Slides stained to identify lymphocyte subsets were 
fixed initially by soaking in acetone, rinsed in a TRIS- 
saline buffer containing BSA and 3 0% BRIJ 3 5 and then fixed 
again in a PLP solution. After fixation, slides were rinsed 
in 0.15 M PBS, pH 7.5, containing fish gelatin.
Slides were paired and incubated with a 1:66 dilution 
of normal horse or goat serum. After the normal serum was 
removed, the slides were incubated with a mouse monoclonal 
anti-lymphocyte subset marker. Monoclonal antibodies and 
dilutions with PBS-gelatin buffer containing BSA used were: 
(neat) anti-human Leu3a+3b [CD4+, T-helper] and (1:2) anti­
human Leu2a [CD8+, T-cytotoxic/suppressor]. After rinsing, 
slides were incubated with a 1:40 biotinylated horse anti­
mouse IgG in PBS-gelatin buffer with BSA. The remainder of 
the procedures were as above with the appropriate PBS- 
gelatin buffer.
Morphometry
Slides of immunocytochemically stained tissues were 
examined using an inverted microscope with a halogen 
transilluminater. A video camera transmitted the image from 
the microscope to video monitors and a microcomputer 
equipped with a mouse. The area of the lamina propria minus 
the crypts was outlined within the computer enhanced field 
of view and measured using a morphometric image analysis 
software program. After the area was delineated and
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measured, immunocytochemically stained cells were 
counted manually. A total of twelve areas were counted from 
the four to five biopsies of each tissue on a slide. 
Statistical Analysis
Circulating lymphocytes, approximated circulating 
lymphocyte subsets, mucosal tissue lymphocyte subsets, 
mucosal tissue IgA-bearing cell counts, and circulating and 
mucosal tissue CD4+/CD8+ cell ratios were evaluated for 
significant differences between the SIV and NEG groups 
using an analysis of variance for repeated measures. If no 
week effect or interaction between variables (group * week) 
was detected, an analysis of variance procedure was 
performed to examine for differences between group means by 
week. A p value < 0.05 was used to reject the null 
hypothesis for all hypothesis testing.
Blood lymphocyte and lymphocyte subsets were 
evaluated as number of cells/microliter of blood. Mucosal 
lymphocyte subset and IgA-bearing cells were evaluated as 
an average cell count per area of lamina propria (cells/mm2 
of lamina propria). For each tissue on a slide, areas and 
cell counts of the twelve fields counted were added and a 
mean cells/mm2 of lamina propria was calculated.
Results
Virus Inoculation
All five monkeys inoculated with SIV/DELTAB670 became 
infected. Reactivity against the SIV p26 protein was found
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in serum from all five on SIV postinoculation day 13 and 
variably thereafter in three of the five monkeys.
Bacterial Inoculation
Campylobacter ieiuni was recultured from rectal swabs 
taken from 4/5 SIV and 4/5 NEG monkeys on postinoculation 
day 3. On postinoculation day 7, gram-negative, gull 
winged-shaped, spirochetes morphologically compatible with 
C. ieiuni were cultured from one of the SIV group culture- 
positive at postinoculation day 3 and the one SIV infected 
monkey that was not positive on postinoculation day 3; 
however, subcultures died and identification to the species 
level as Ĉ _ ieiuni could not be confirmed. Campylobacter 
ieiuni was not cultured from any of the monkeys during 
postinoculation week 2. During postinoculation week 4, C. 
ieiuni was cultured from 1/5 SIV infected monkeys. 
Campylobacter ieiuni was not cultured from any of the NEG 
group of monkeys after postinoculation day 3.
Clinical Findings
No clinical gastrointestinal signs of disease were 
observed in either the SIV or NEG monkeys during the period 
of this study. Diarrhea was noted in the end-stage SIV- 
disease phase for 3/5 of the SIV monkeys after this study 
was completed and the monkeys had been assigned to another 
study. Other clinical signs observed in SIV monkeys during 
this study were enlarged internal organs (3/5), variable 
peripheral lymphadenopathy (3/5), and mild dermatitis of 
undetermined etiology (5/5). Conjunctivitis of undetermined
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etiology (2/5) and dermatitis (1/5) was observed in NEG 
monkeys.
Because none of the animals developed gastrointestinal 
illness during the period of the study, hematology and 
clinical chemistries were performed sparingly. During the 
period of the study the hematocrits of one SIV and two NEG 
monkeys decreased slightly. The total white blood cell, 
neutrophil and lymphocyte counts, and the clinical 
chemistry results were unremarkable.
Endoscopic examination found mild gross changes in 
some of the monkeys in both groups. The change noted in one 
monkey in the NEG group was mild pyloric hyperemia with a 
mildly roughened duodenal mucosa in another. Changes in the 
SIV group included a transient, thickened, velvety large 
colonic mucosa in one monkey, transient mild multifocal 
ulceration in another monkey, and transient hyperemia with 
occasional white foci in the pyloric mucosa of a third 
monkey.
Histopathologic lesions were rarely observed. Rare 
focal accumulations of neutrophils were associated with 
microulcerations of the epithelium and focal villus atrophy 
which were interpreted to be sites of previous mucosal 
biopsies. Very rare distended crypts lined by flattened 
epithelium were observed in two SIV monkeys (K018, K032) 
during postinoculation week 1 and in one NEG monkey (K010) 
during postinoculation week 4.
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ELISA
A specific antibody response to the experimental oral 
inoculation of CL. ieiuni was observed in monkeys from both 
the NEG- and SIV-infected groups in both the serum and 
intestinal contents. These responses indicated that the 
inoculation procedure had stimulated both the enteric 
secretory and systemic immune systems of the monkeys.
Within each group the response over the period of study 
varied between individual monkeys depending on the isotype 
of immunoglobulin and sample source examined; however, the 
responses of the SIV monkeys, taken as a group, were 
impaired compared with the NEG group.
Serum anti-C. ieiuni IgA responses in SIV infected 
monkeys were nonexistent to weak compared with the moderate 
to strong responses in the majority of the NEG group, but 
the highest titers in both groups was 1:1280 measured as 
the end-point dilution of serum (Figure 4.1). In the SIV 
group, 4/5 had no or a minimal response. One (K013) had an 
existing moderate titer that decreased. One (K018) had no 
initial titer that did not increase. Two (K008, K020) had 
only weak increases and one (K032) had a moderate increase 
in titer. In contrast, 3/5 (K019, K026, K035) in the NEG 
group had relatively strong responses. One (K010), the one 
monkey from which Ck_ ieiuni was not recultured after 
inoculation, had a weak response. One (K025) had a 















































Figure 4.1. Graphs o f anti-C. ieiuni IgA in the serum of rhesus monkeys not infected (NEG) or previously infected (SIV) with
SIV/DELTA B670 and inoculated orally with C. jejuni at week (0)
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Similarly, serum anti-C. ieiuni IgG responses in SIV- 
infected monkeys, with one notable exception, were weak to 
nonexistent compared to moderate to strong responses in the 
majority of the NEG group. (Figure 4.2). The patterns of 
specific anti-C. ieiuni IgG response in individual monkeys 
were similar to the pattern of the specific anti-C. ieiuni 
IgA response. In the SIV group, 4/5 had no or a minimal 
response. Two (K018, K013) had no or a very low initial 
titer that did not increase. Two (K008, K020) had only weak 
increases and one (K032) had a strong increase in titer. In 
contrast, 3/5 (K019, K026, K035) in the NEG group had 
strong responses. One (K010), the monkey from which C . 
ieiuni had not been recultured after experimental 
inoculation, again had a weak response. One (K025), which 
had a preexisting titer but no increase in anti-C. ieiuni 
IgA, had a moderate increase in anti-C. ieiuni IgG titer.
Examination of intestinal contents resulted in a much 
cruder measurement of the anti-C. ieiuni IgA (Figure 4.3) 
compared to examination of the serum. Measurable titers 
were, as anticipated, (Winsor, et al., 1986) much lower 
than in the serum and ranged only up to 1:32 measured as 
the end-point dilution of the processed fluids. In general, 
the trend of the titers in the colonic contents reflected 
those observed in the serum although the magnitude of the 
response was not always proportional. In 8/10 monkeys, an 
increasing anti-C. ieiuni IgA titer in the serum was 
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Figure 4. 2. Graphs of anti-C. ieiuni IgG in the serum of rhesus monkeys not infected (NEG) or previously infected (SIV) with
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Figure 4.3. Graphs o f anti-C. ieiuni IgA-units in the duodenal and colonic intestinal contents of rhesus monkeys not infected
(NEG) or previously infected (SIV) with SIV/DELTA B670 and inoculated orally with C. ieiuni at week (0).
87
colonic contents. The two exceptions (K018, K02 5) showed 
increases in colonic anti-C. jejuni IgA after inoculation 
but no increase of anti-C. jejuni IgA in the serum. The 
trend of the titers in the duodenal contents were much less 
consistent than the colonic contents. In only 3/10 monkeys 
was the trend of the anti-C. jejuni IgA titer in the 
duodenal contents reflective of the serum anti-C. jejuni 
IgA titer. The colonic and the duodenal contents titers 
were compared with the serum titers which are much less 
susceptible to degradation, dilution, or nonspecific 
interference. Since the colonic contents titers were more 
reflective than the duodenal contents titers of the serum 
titers, the colonic contents titers will be used in the 
remainder of the chapter to make comparisons involving the 
anti-C. jejuni IgA in intestinal contents.
Colonic anti-C. jejuni IgA responses were observed in 
3/5 SIV infected monkeys. One (K008) had a weak increase in
the enteric secretory and the serum anti-C. jejuni IgA
titer. The second (K018) had a weak enteric secretory 
antibody response but did not develop a serum titer. The 
third (K032) had the highest anti-C. jejuni IgA titer 
levels of the SIV group in the colonic contents and the 
greatest increase in titer of the SIV group in the serum. 
One (K013) SIV monkey that showed a decrease in the colonic 
anti-C. jejuni IgA titer had a decrease in the serum titer. 
One (K020) had a variable low titer. In the NEG group, 5/5
had an increased titer at some point during or over the
8 8
entire period. Two (K019, K025) had strong anti-C. jejuni 
IgA responses. One of these (K019) had a corresponding 
strong increase in the serum titer while the other had a 
moderate preexisting titer that remained stable. The 
remaining three (K010, K026, K035) had weak and transient 
colonic anti-C. jejuni IgA responses. Of these three, one 
(K010) had a weak response in the serum while two (K02 6,
K03 5) had strong serum responses.
Titers of serum total IgA and IgG were similar for the 
SIV and NEG groups of monkeys (Figure 4.4) but varied 
between animals within a group especially for IgA in both 
groups. In the SIV group, serum total IgA titers ranged 
from 1:3,200 (log of the reciprocal of the serum dilution 
[LRD] = 3.51) to 1:102,400 (LRD = 5.01). In the NEG group, 
serum total IgA titers ranged from 1:6,400 (LRD = 3.81) to 
1:102,400 (LRD = 5.01). In the SIV group, serum total IgG 
titers ranged from 1:25,600 (LRD = 4.41) to 1:102,400 (LRD 
= 5.01). In the NEG group, serum total IgA titers ranged 
from 1:25,600 (LRD =4.41) to 1:51,200 (LRD = 4.71). There 
was no pattern of changes in serum total IgA or IgG 
resulting from experimental inoculation with CL. jejuni. 
Lymphocyte subsets
For comparison of the SIV and NEG groups and 
individual monkeys within groups, numbers of circulating 
lymphocyte subsets were approximated for each monkey by 
multiplying the percentage of the total blood mononuclear 
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Figure 4.4. Graphs o f IgA and IgG titerssn the serum o f rhesus monkeys not infected (NEG) or previously infected (SIV) with
SIV/DELTA B670 and inoculated orally with C. ieiuni at week 0. Titers are expressed as the log o f the reciprocal o f the serum
end-point dilution
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total blood lymphocyte count from simultaneously collected 
blood. CD4+CD29+ cell numbers were determined for each 
animal by multiplying the CD4+ cell number by the 
percentage of CD4+CD29+ cells.
Total blood lymphocyte and lymphocyte subset analysis 
for each monkey were performed before (week -1) and near 
the end (week 3) of the period of study after experimental 
C. jejuni inoculation. Total blood lymphocyte counts varied 
between weeks within an animal (Figure 4.5). Counts were 
generally higher in the NEG group but the difference 
between groups was not statistically significant using the 
analysis of variance for repeated measures procedure. No 
significant week effect or interaction between group and 
weeks were detected indicating no compound effect due to 
the Cj_ jejuni or SIV inoculations. An analysis of variance 
found a significantly lower statistically mean number of 
circulating lymphocytes (p = 0.015) for the SIV group 
during week 3. Although the NEG group had higher total 
lymphocyte counts and a greater serologic response overall, 
inspection of plotted data revealed that the total number 
of lymphocytes was not predictive of an antibody response 
or the strength of the response for individual monkeys.
The results of the analysis of variance for repeated 
measures of the circulating CD4+ cells data were similar to 
those for the total lymphocytes. Counts varied between 
weeks within an animal (Figure 4.6). Counts were generally 
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Figure 4.5. Graphs o f circulating total lymphocytes with serum anti-C. ieiuni IgA and IgG in rhesus monkeys grouped as not
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Figure 4.6. Graphs o f approximated relative absolute CD4+ circulating blood mononuclear cells with serum anti-C. ieiuni IgA and
IgG in rhesus monkeys grouped as not infected (NEG) or previously infected (SIV) with SIV/DELTA B670 and orally inoculated
with C. ieiuni at week (0).
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approached statistical significance (p=.065). No week 
effect or interaction between group and weeks was detected. 
An analysis of variance found a significantly lower 
statistically mean number of circulating CD4+ cells (p = 
0.036) for the SIV group during week 3. Inspection of 
graphed data showed that the number of CD4+ cells was more 
predicitive of the strength of an antibody response than 
total lymphocytes in an individual monkey but not 
consistently. Three of four SIV monkeys (K008, K013, K018) 
with CD4+ counts below 1500 cells/jitl blood had no to weak 
anti-C. ieiuni antibody responses while one (K032) had a 
strong antibody response. All monkeys in the NEG group had 
CD4+ cell counts above 1500 cells/jul blood.
Circulating CD8+ cells were not significantly 
different statistically between SIV and NEG groups (Figure 
4.7). Within the SIV group, greater numbers of CD8+ cells 
were usually associated with a lack of or weak anti-C. 
ieiuni systemic antibody responses (K008, K013, K018), but 
a monkey in the NEG group with as great or greater numbers 
of CD8+ cells had strong responses (K035). The SIV monkey 
with the lowest CD8+ cell count (K020) had a weak response 
while the NEG monkey with the lowest counts (K02 6) had a 
moderate response.
The circulating CD4+/CD8+ ratios of the SIV and NEG 
groups were not significantly different statistically but 
were generally lower in the SIV group except for one monkey 
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Figure 4.7. Graphs o f approximated relative absolute CD8+ circulating blood mononuclear cells with serum anti-C. ieiuni IgA and
IgG in rhesus monkeys grouped as not infected (NEG) or previously infected (SIV) with SIV/DELTA B670 and orally inoculated
with C. ieiuni at week (0).
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other monkeys in the SIV group (Figure 4.8). CD4+/CD8+ cell 
ratios < 1 were associated with weak systemic anti-C. 
ieiuni responses in three SIV monkeys (K008, K013, K018) 
but strong responses in one SIV monkey (K03 2) and one NEG 
monkey (K035). High ratios were not associated with the 
stronger systemic antibody responses in the NEG or SIV 
groups.
Circulating CD4+CD29+ cells were significantly lower 
statistically (p = 0.002) in the SIV group compared with 
the NEG group (Figure 4.9). No week effect or interaction 
between group and week were detected indicating there was 
no compound effect caused by the C^ ieiuni and SIV 
inoculations. An analysis of variance found mean CD4+CD29+ 
cell numbers for the SIV monkeys were significantly lower 
statistically (p < 0.05) for both sampling dates. As with 
the CD4+ cells and the CD4+/CD8+ ratios, low CD4+CD29+ 
cells counts were associated with a lack of or a weak anti­
cs ieiuni systemic antibody response in three SIV monkeys 
(K008, K013, K018), but a strong response in another 
(K032). The remaining SIV monkey (K020) had CD4+CD29+ cell 
counts that were comparable to counts in the NEG group but 
had only a weak response. The numbers of CD4+CD2 9+ counts 
in the NEG group were similar between individual monkeys 
with no correlation between the numbers of cells and the 
level of the antibody response.
Mucosal colonic lymphocyte subset populations were 
evaluated and compared with colonic contents anti-C. ieiuni
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Figure 4.8. Graphs o f approximated CD4+/CD8+ circulating blood mononuclear cells ratio with serum anti-C. jejuni IgA and IgG
in rhesus monkeys grouped as not infected (NEG) or previously infected (SIV) with SI V/DELTA B670 and orally inoculated with
C. ieiuni at week (0).
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Figure 4.9. Graphs o f approximated relative absolute CD4+CD29+ (DBLT4+) circulating blood mononuclear cells with serum
anti-C. ieiuni IgA and IgG in rhesus monkeys grouped as not infected (NEG) or previously infected (SIV) with SIV/DELTA B670
and orally inoculated with C. ieiuni at week (0).
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IgA (Figure 4.10) and serum anti-C. ieiuni IgA and IgG 
(Figure 4.11). No statistically significant difference 
between SIV and NEG monkeys was detected for T helper 
(CD4+) cells/mm2 of colonic lamina propria. No week effect 
or interaction between group and week were found indicating 
there was no compound effect due to the Ch. ieiuni and SIV 
inoculations. Examining individual monkeys, the numbers of 
CD4+ cells varied between the four sample dates and were 
not indicative of a enteric secretory or systemic anti-C. 
ieiuni antibody response occurring or the strength of a 
response.
A statistically significant greater (p = 0.016) number 
of T cytotoxic/suppressor (CD8+) cells/mm2 of colonic 
lamina propria was found for the SIV group compared with 
the NEG group in the colonic mucosa. The increased numbers 
of CD8+ cells did inversely correspond with the generally 
weaker anti-C ieiuni enteric secretory and systemic 
antibody response of the SIV group; however, when examining 
individual monkeys within a group, the number of CD8+ cells 
was not strongly indicative of the level of the antibody 
response. In the SIV group, one of the two monkeys with the 
consistently higher CD8+ cell numbers (K013) had no enteric 
secretory anti-C ieiuni IgA response and no systemic 
increase in anti-C ieiuni IgA or IgG while the other monkey 
(K032) had strong enteric secretory and systemic responses. 
Conversely, the monkey (K035) with the highest numbers of 
CD8+ cells in the NEG group had a moderate enteric
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Figure 4.10. Graphs of CD4+ and CD8+ cells/m m 2 of colonic lamina propria and colonic contents anti-C. ieiuni IgA-units in
rhesus monkeys grouped as not infected (NEG) or previously infected (SIV) with SIV/DELTA B670 and orally inoculated with C
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Figure 4.11. Graphs o f CD4+ and CD8+ cells /mm2 of colonic lamina propria with serum anti-C. jejuni IgA and IgG in rhesus
monkeys grouped as not infected (NEG) or previously infected (SIV) with SIV/DELTA B670 and orally inoculated with C. ieiuni at
week (0).
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secretory and strong systemic anti-C ieiuni antibody 
response. No week effect or interaction between group and 
week was detected indicating that no compound effect was 
caused by the Ĉ _ ieiuni and SIV inoculations.
The difference for the ratios of CD4+/CD8+ cells/mm2 
of lamina propria in the colon between SIV and NEG groups 
approached (p < 0.08 6) but was not statistically 
significant. No week or interaction between group and week 
was detected by the repeated measures statistical procedure 
indicating no compound effect due to the Ĉ _ ieiuni and SIV 
inoculations. An analysis of variance found a significant 
decrease statistically (p = 0.049) in the SIV group mean 
CD4+/CD8+ cell ratio for week 1. The trend of decreased 
CD4+/CD8+ ratios in the SIV group corresponded with the 
generally weaker anti-C. ieiuni antibody enteric secretory 
(Figure 4.12) and systemic responses (Figure 4.13).
However, as with the CD8+ cell numbers, the ratios varied 
among the four sampling dates within individual monkeys and 
the trend of the ratios was not indicative of an enteric 
secretory or systemic anti-C. ieiuni response or the 
strength of a response.
No statistically significant difference between SIV 
and NEG monkeys was detected for IgA+ cells /mm2 of lamina 
propria in the colon. There was a weak trend to fewer IgA+ 
cells in the colons of the SIV group compared to the NEG 
group. As with the other mucosal cell types, IgA+ cell 
numbers were not indicative of an enteric secretory (Figure
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Figure 4.12. Graphs o f CD4+/CD8+ cell ratio in colonic lamina propria with anti-C. ieiuni IgA-units in colonic contents in rhesus
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Figure 4.13. Graphs o f CD4+/CD8+cell ratio in colonic lamina propria with serum anti-C. ieiuni IgA and IgG in rhesus monkeys
grouped as not infected (NEG) or previously infected (SIV) with SIV/DELTA B670 and orally inoculated with C. ieiuni at week (0).
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Figure 4.14. Graphs o f IgA+ cells in colonic lamina propria with anti-C. ieiuni IgA units in colonic contents in rhesus monkeys
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Figure 4.15. Graphs o f IgA+ cells in colonic lamina propria with serum anti-C. jeiuni IgA in rhesus monkeys grouped as not
infected (NEG) or previously infected (SIV) with SIV/DELTA B670 and orally inoculated with C. ieiuni at week (0).
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4.14) or systemic (Figure 4.15) anti-C. ieiuni antibody 
response or the strength of the response.
For the NEG group only, there was a weak relationship, 
determined by inspection of the plotted data, between the 
numbers of circulating CD4+ and CD8+ cells and the numbers 
of mucosal tissue CD4+ and CD8+ cells. For individual 
animals, higher circulating numbers of CD4+ or CD8+ cells 
were associated with higher numbers in the mucosa. No such 
relationships were discerned for the SIV group.
Discussion
The results of studies in this chapter have 
demonstrated that impaired functional specific secretory 
and systemic antibody responses to ieiuni are associated 
with alterations in the cell numbers of several cellular 
subpopulations of the mucosal immune system and circulating 
lymphocyte subsets in the SIV-infected rhesus monkey. The 
impairment in the specific antibody response was associated 
with longer periods of colonization with Ĉ . ieiuni in the 
SIV group, but signs of clinical disease or characteristic 
lesions were not observed.
Development of a specific IgA secretory and systemic 
antibody response are thought to be important in 
eliminating the bacteria and recovery from and resistance 
to campylobacteriosis. Cultures for C\_ ieiuni from rectal 
swabs taken three days after experimental inoculation found 
8/10 monkeys colonized. One of the 2/10 monkeys not 
culture-positive was not SIV-infected and developed weak
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secretory and systemic specific antibody responses. The 
inoculum used was assumed to be viable as the other monkey 
inoculated that day became infected. The rectal swab 
sampling process may not have obtained an adequate amount 
of fecal contents to permit isolation of Ch. ieiuni. a 
fastidious organism. The second monkey was culture-positive 
on postinoculation day 7. Campylobacter ieiuni was cultured 
from one and possibly three of the SIV monkeys on 
postinoculation day 7. Subcultures morphologically 
compatible with Ĉ _ ieiuni from two of the three monkeys 
died before classification to the species level was 
completed. One of these three was culture-positive again on 
postinoculation day 28. All three of these monkeys had weak 
or decreasing systemic specific antibody responses and no 
mucosal response.
After postinoculation day 3, Ch. ieiuni was not 
cultured from any of the NEG monkeys. The finding that 
rabbits had periods of colonization that dropped from an 
average of 18 days after initial oral inoculation to an 
average of three days after attempted oral reinfection with 
C. ieiuni (Caldwell, et al., 1983) suggests that these 
monkeys may have been previously exposed to Ch. ieiuni. 
Anamnestic secretory antibody responses are less 
characterized than systemic responses. In one study using 
rabbits inoculated once orally or orally each week for 
three weeks with Shigella flexneri and rested 60 days, 
reinoculation with the same bacterial strain resulted in no
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priming for the rabbits inoculated once but a rapid strong 
elevation in the secretory anti-S. flexneri IgA titer 
occurring within three days in the rabbits primed with the 
three weekly doses (Keren, Collins, Gemski, Holt, & Formal, 
1982) . Only one of the monkeys (K032) had a rise in 
secretory titer at postinoculation day 7. Systemic 
responses to oral antigens have been reported to vary from 
stimulation to suppression depending on the antigen and 
protocol of administration (Peri & Rothberg, 1981). One 
monkey (K019) had a specific systemic IgA response 
suggestive of an anamnestic response. Two other monkeys had 
elevated existing specific systemic IgA titers suggestive 
of previous exposure.
Inoculation of Ĉ _ ieiuni did not produce clinical 
signs or histopathologic lesions suggestive of 
campylobacteriosis in SIV or NEG monkeys. Others (Blaser, 
1987; Melamed, et al., 1988) have indicated the importance 
of specific antibody responses in resolution of clinical 
campylobacteriosis by noting the persistence of infection 
in hypogammaglobuinemic patients. Similarly, persistent C . 
ieiuni infections have been observed in AIDS patients with 
abnormally low anti-Campylobacter antibodies in serum 
(PerImam et al., 1988). Since most of the SIV monkeys had 
no or a weak specific secretory and systemic anti-C. ieiuni 
antibody response, the reasons no disease was observed in 
the monkeys is unclear.
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The isolate was obtained from a rhesus monkey that 
died from enterocolitis. No other pathogens were identified 
during the clinical or necropsy examinations. Historically, 
production of campylobacteriosis in experimental animal 
models has been inconsistent with multiple animal passages 
to enhance virulence recommended by some (Kazmi, Roberson,
& Stern, 1984). Although subculturing was kept to a 
minimum, four times in this case, virulence may have 
decreased during in vitro passages necessary for initial 
isolation and experimental inoculum production.
Other protective mechanisms may have a role in 
protection from clinical disease but evaluation of these in 
other studies is rare. In one study (Melamed, Zakuth, 
Schwartz, & Spirer, 1988), after exposure to ieiuni 
antigens, lymphocyte stimulation in a transformation assay 
was significantly greater statistically from the ieiuni 
positive patients versus controls. The Ĉ _ ieiuni positive 
patients included a hypogammaglobulinemic patient with a 
poor lymphocyte stimulation response and persistent 
campylobacteriosis suggesting that cellular immunity may be 
important in protection from campylobacteriosis.
As suggested by the colonization and specific antibody 
studies, both the SIV and NEG monkeys may have been exposed 
to ieiuni in the past. Two of the monkeys (K013, K025) 
had moderate initial titers suggesting previous exposure. 
Previous exposure could have increased their resistant to 
the development of clinical disease. In studies of
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experimental Ch. ieiuni inoculation of humans (Black, et 
al., 1988), rechallenge with homologous strains resulted in 
variable colonization but no clinical illness.
No microscopic lesions attributable to Ck_ ieiuni or 
SIV were observed. Microscopic lesions were not observed in 
biopsies taken from K019 that had occasional one to two mm 
hyperemic foci in the duodenum during postinoculation week 
2. The foci were thought to be earlier biopsy sites based 
on microscopic findings of focal microulcerations moderate 
numbers of neutrophils attributed to biopsy sites in other 
sections. No microscopic lesions were observed in sections 
of week 4 colon biopsies from K018 thought to have a 
thickened mucosa during endoscopic exam.
There are an increasing number of reports describing 
measurement in the feces of specific IgA against a variety 
of microorganisms including Ck_ -jejuni (Winsor, et al.,
1986; Vinayak, Dutt, & Puri, 1991) or other antigens. 
Although crude, measurements of mucosal secretory fluids 
are suitable for answering certain types of questions. For 
certain species of animals, such as small rodents or non­
domesticated animals including nonhuman primates, the 
ability to measure antibody responses to environmental or 
experimental antigens from fecal or other excretory or 
secretory specimens would be advantageous in terms of 
safety and convenience for the animal and animal handlers.
Experimental administration of soluble or particulate 
antigens orally, such as ovalbumin, over an extended period
I l l
of weeks generally results in a specific IgA response 
occurring at the level of the mucosa and in systemic 
unresponsiveness (Fujihashi, et al., 1988). Specific 
antibody responses to infection by Ch_ ieiuni have been 
reported to occur at both the mucosal and systemic level 
(Lane, Batchelor, Bourgeois, Burr, & Olson, 1987; Kaldor, 
et al., 1983). Serum responses to a whole cell Vibrio 
cholerae vaccine administered orally have been described as 
good serological correlates with the gut mucosal IgA immune 
responses (Jertborn, Svennerholm, & Holmgren, 1992). Yet 
others, (Winsor, et al., 1986) indicate that a systemic 
response may not always accompany a secretory response to a 
mucosal pathogen.
Thus, because of the various interpretations of 
results brought on by the complexity of the immune system, 
both secretory and systemic responses to the inoculated C. 
ieiuni were examined to evaluate the effect of SIV 
infection. Because of concerns about degradation of IgA in 
feces collected at irregular intervals from cage pans and 
stored for variable periods before processing, colonic 
contents were collected at the time of biopsy and duodenal 
contents collection. This varies from previously described 
methods and subjected the contents collected to dilution 
with fluids administered during the enema required for the 
endoscopic procedure. Still, the results from the colonic 
fluids correlated better with the serum response than the 
duodenal contents. Results from the duodenal contents may
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have been adversely affected by mucus that was frequently 
present or other materials in the collected fluids that may 
have nonspecifically interfered with the antigen-antibody 
reaction phase of the ELISA.
Because of the possible dilution from the enema, 
variable water ingestion, and possible difference in gut 
motility, results were referenced to levels of total IgA in 
the contents. Total IgA was thought to be the most 
standarizable parameter for measurements between monkeys 
and has been used by others (Cancellieri & Fara, 1985). 
Levels of total serum IgA was not observed to be different 
between SIV and NEG monkeys but did vary among individual 
monkeys.
Trends in whether an animal did or did not develop a 
response, but not necessarily in the strength of the 
response, were observed in 8/10 of the monkeys. In the 2/10 
monkeys (K018, K025) that were different, both had no 
systemic IgA response and one (K025) had a weak systemic 
IgG response. Neither were culture positive for jejuni 
after postinoculation day 3. Thus, as has been suggested, a 
mucosal response may have occurred resulting in the 
clearance of the bacteria at the mucosal level only.
The studies reported here indicate that there is 
impairment of specific anti-C. jejuni secretory antibody 
responses in SIV-infected rhesus monkeys. They also suggest 
the usefulness of measuring fecal antibodies in rhesus
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monkeys for a variety of studies but evaluation of larger 
numbers of monkeys are needed.
Secretory and systemic titers were compared with 
circulating and mucosal cell subset numbers. In the SIV 
group, two monkeys (K032, K020) disrupted any pattern of 
association between increased or decreased cell populations 
in SIV monkeys and impairment of the specific antibody 
response.
Only one SIV monkey (K032), had a moderate anti-C. 
jejuni IgA systemic response and strong systemic IgG and 
secretory IgA responses. The reason this monkey had the 
strongest responses is not clear. Two other SIV monkeys had 
absence of antigenemia for comparable lengths of time. One 
of those two monkeys is still alive 30 months after 
completion of the study. Two SIV monkeys had lower initial 
levels of antigenemia. K032 had the lowest numbers of 
circulating lymphocytes and low numbers of circulating CD4+ 
and CD+CD29+ cells compared with other monkeys in the 
group. Mucosal CD4+ and CD8+ cell numbers were near the 
high end of the group but not appreciably greater. If, as 
has been suggested, the reason for the impaired antibody 
response is a reduction in regulatory cytokine production, 
then possibly the cytokine-producing cells responsive to C. 
jejuni in K032 have escaped, perhaps randomly, the effects 
of the virus.
The other monkey (K020) had no mucosal and relatively 
weak systemic antibody responses but the highest
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circulating CD4+ and lowest CD8+ cell numbers in both 
groups. The number of CD4+CD29+ cells in this monkey were 
the highest in the SIV group.
Thus cell numbers alone were unable to explain the 
overall impaired specific antibody response in SIV monkeys 
as a group. No population number for any subset of cells or 
cell ratio could be used as an index to consistently 
predict an impaired specific antibody response.
The CD4+CD29+ cells were the best predictor of an 
impaired antibody response among the circulating cells 
measured. Circulating CD4+CD29+ cells were significantly 
decreased statistically and associated with the impaired 
specific antibody response in the SIV compared to the NEG 
group. The CD4+CD29+ cells are a subset of CD4+ cells 
refered to as "helper/inducer" or "memory" that have been 
found important in providing B cell help for immunoglobulin 
production in vitro in response to soluble and recall 
antigens (Schnittman, Lane, Greenhouse, Justement, Baseler, 
& Fauci, 1990). Furthermore, this cell subset is 
preferentially infected by the HIV-1 virus and has failed 
to respond systemically to the soluable antigen, tetanus 
toxoid, in AIDS patients. Since the progression of the 
immunodeficiency induced by SIV varies between individual 
monkeys, monitoring decreases in numbers of circulating 
CD4+CD29+ cells might be useful as a guide for timing 
future studies examining the early alterations in the 
mucosal immune system. Attempts to perform a double
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staining immunocytochemical technique looking for these 
cells in mucosal tissues were unsuccessful. Monitoring 




AIDS, a new class of disease caused by apparently 
recently evolved etiologic agents, has emerged as a fatal 
disease feared by the individual, a major burden to human 
health care organizations worldwide, and a challenge for 
the biomedical research community. Approximately one-half 
of AIDS patients have signs of gastrointestinal dysfunction 
usually caused by infectious agents. AIDS is caused by the 
immunosuppressive retroviruses HIV-1 or HIV-2 which are 
closely related to SIV. Non-human primates experimentally 
infected with SIV develop a systemic immunodeficiency 
syndrome very similar to AIDS and develop fatal diseases 
caused by opportunistic pathogens or pathogens that usually 
have self-limiting clinical courses. The SIV infected M. 
mulatta has been recommended as an excellent animal model 
for the study of various aspects of AIDS. The studies 
described here document alterations in enteric mucosal 
immune system cell populations and functional humoral 
responses to the enteric bacterial pathogen C_̂  jejuni 
recommending the further utilization of this animal model 
for studies into the basic pathogenesis of the 
gastrointestinal dysfunction observed in many AIDS 
patients.
The five juvenile IL mulatta inoculated became 
infected with SIV as confirmed by measuring post­
inoculation SIV p26 antigenemia. After an early period of
116
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antigenemia in all five, the reappearance, if observed, and 
pattern of antigenemia, varied in individual monkeys for 
time of reappearance and levels at the time of death, if 
death occurred.
The SIV monkeys were compared with similar rhesus 
monkeys not infected with the virus (NEG) before and after 
both groups were orally inoculated with jejuni. 
Endoscopic techniques proved to be an effective and 
relatively innocuous means for serially obtaining mucosal 
biopsies and intestinal contents from mulatta for study.
In similarity to reports describing studies on 
specimens from the enteric mucosa of AIDS patients, 
statistically significant increased numbers of T 
cytotoxic/suppressor (CD8+) cells and IgM+ cells, as 
identified by specific immunocytochemical stains, were 
observed in the lamina propria of the enteric mucosa of the 
SIV monkeys. Although not statistically significant as in 
AIDS patients, a trend to decreased numbers of IgA+ cells 
and decreased CD4+/CD8+ cell ratios in the colonic mucosa 
of the SIV-infected monkeys was appreciated by inspection 
of the plotted data.
In contrast, T helper (CD4+) cells in the mucosa were 
not significantly different statistically between the 
monkey groups. The CD4+/CD8+ mucosal cells ratio was lower 
than reported for human controls in several, but not all, 
studies involving AIDS patients indicating there are either 
fewer CD4+ cells or more CD8+ cells in the mucosa of rhesus
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monkeys compared with humans. This possible species 
difference between human and monkey merits further study as 
decreased numbers of mucosal CD4+ cells in AIDS patients 
have been considered important in the pathogenesis of the 
various gastrointestinal infections observed in AIDS 
patients.
No statistically significant differences were noted 
for CD8+ intraepithelial lymphocytes in the duodenal or 
colonic surface epithelium. By semiquantitative evaluation, 
no differences were noted between the SIV and NEG monkeys 
for mucosal lamina proprial neutrophil, eosinophil, or mast 
cell populations with the histologic stains used.
Evaluation of circulating cell populations found 
statistically significant decreases in T helper/memory 
(CD4+CD29+) cells in the SIV group compared with the NEG 
group. In vitro. human CD4+CD29+ cells function in 
supporting immunoglobulin production by B cells. Decreases 
in total lymphocytes and relative absolute numbers of CD4+ 
cells were seen and approached statistical significance in 
SIV monkeys. No statistically significant difference was 
observed for circulating CD8+ cells.
The pattern of specific anti-C. jejuni systemic and 
enteric secretory antibody responses for the SIV monkeys 
taken as a group were impaired compared with the NEG group 
both in the numbers of monkeys developing responses and the 
levels of the responses. The differences in the levels of 
response could not be attributed to a difference in total
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immunoglobulins between SIV and NEG monkeys. Systemic anti­
cs ieiuni IgA and IgG within individual animals were 
comparable. In the SIV group, two monkeys had no or a 
decreased specific IgA response, two had weak responses and 
one had a moderate response. In the NEG group, one monkey 
with a preexisting moderate titer had no response, one 
monkey had a weak transient response, and three monkeys had
strong responses. In the SIV group, two monkeys had no
specific IgG response, two had weak responses and the same 
monkey that had a strong IgA response had a strong IgG 
response. In the NEG group, two monkeys had moderate 
responses and three monkeys had strong responses.
The enteric secretory specific anti-C. -jejuni IgA was 
a cruder measure of the humoral response to Ĉ _ jejuni than 
the serum antibody. For the colonic contents, titers of 
specific antibody in 8/10 monkeys, although much lower, 
reflected similar trends occurring in the serum. For the 
remaining 2/10, a secretory response without a 
corresponding systemic response could represent a response 
only at the level of the mucosa. As in the serum, responses
were impaired in the SIV group as compared with the NEG
group. Results from the duodenal contents showed poor 
correlation with the results from the serum.
Comparison of the different cell populations were made 
with the specific antibody response. When considering 
overall responses of the groups, statistically significant 
decreased numbers of circulating CD4+CD29+ and increased
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numbers of mucosal CD8+ and IgM+ cells were associated with 
generally weaker specific systemic and mucosal IgA and IgG 
antibody responses. Decreased numbers of circulating 
lymphocytes and CD4+ cells and mucosal IgA+ cells and 
CD4+/CD8+ ratios in the SIV group were also associated with 
generally weaker specific systemic and mucosal responses, 
although results were not statistically significant. 
However, when applied to individual monkeys, none of the 
alterations in cell populations observed consistently 
correlated with an impaired antibody response. Thus in this 
study using a limited number of monkeys, alterations in 
cell populations below or above a certain level alone could 
not explain the apparent impaired antibody response 
observed in the SIV group. A decrease in the number of 
circulating CD4+CD29+ cells or increase in the number of 
mucosal CD8+ cells were suggested by these studies as 
monitorable changes that could be used to identify the 
initial stage of SIV-induced immunosuppression for future 
studies.
Although there was a generally poor specific anti-C. 
ieiuni systemic and secretory antibody response and 
prolonged colonization of the gastrointestinal tract by C. 
ieiuni after experimental inoculation in monkeys in the SIV 
group, no clinical signs or histopathologic lesions 
suggestive of campylobacteriosis were observed, not even in 
individual monkeys with no antibody response. This result 
was unexpected since previous studies had suggested the
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importance of specific antibody for immunity from clinical 
disease. Potential explanations for this failure to produce 
clinical disease include the possiblity that the C\_ ieiuni 
isolated was not the cause of the enterocolitis in the 
index monkey. Despite efforts to minimize the amount of 
subculturing, the isolate may have lost virulence during in 
vitro manipulation. The monkeys may have been exposed to C . 
ieiuni in the past altering their susceptibility. Other 
factors, such as cellular immunity, may be more important 
than currently appreciated in defense against 
campylobacteriosis. Historically, inconsistent results have 
occurred in attempts to produce campylobacteriosis in 
experimental animals.
Inoculation of ieiuni was not shown to have caused 
changes in the T cell subsets or plasmacyte populations 
responding specifically to Ĉ _ ieiuni that were adequate to 
induce statistically significant differences in the overall 
populations of the cells measured. Since an induced, 
specific antibody response was documented, further studies 
are indicated to determine if the difference in the 
response between the SIV and NEG monkeys was caused by 
decreased numbers of specifically responding cells, 
functional deficits, or a combination of factors.
Further studies using this model are warranted to 
define the pathogenesis of the morphologic alterations in 
the mucosal immune system cell populations, the 
relationship with the functional impairment in the specific
122
humoral response, and the factors involved in immunity to 
enteric pathogens.
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